Session ID,Hall,Presentation ID,Time,Details
,,W0009,08:30,"Sampling and culturing anaerobesHugo Cruz (Porto, Special Session Portugal) Antimicrobial Stewardship in Different Scenarios W0010 08:50 I have an anaerobe: what is it and does it matter?Kathleen Boiten (Groningen, Netherlands) Chairs Murat Akova (Ankara, Türkiye) Andre Fuchs (Augsburg, Germany) W0011 09:10 Actinomyces in clinical samples: when is it worth the Maddalena Giannella (Bologna, Italy) trouble?Eija Inkeri Könönen (Turku, Finland) Angela Huttner (Geneva, Switzerland) W0012 09:30 Nocardiosis: when to test and how to manage Benedikt Huttner (Geneva, Switzerland) results?David Lebeaux (Paris, France) Jose Ramon Pano-Pardo (Zaragoza, Spain) Co-organised with: ESCMID Study Group for Anaerobic Infections (ESGAI), Galadriel Pellejero-Sagastizábal (Zaragoza, Spain) ESCMID Study Group for Clostridioides difficile (ESGCD) Holger Rohde (Hamburg, Germany) Oana Sandulescu (Bucharest, Romania) Jeroen Schouten (Nijmegen, Netherlands) Valentijn Schweitzer (Utrecht, Netherlands) EW004 08:30 - 10:30 Hall 6 Thomas Tängdén (Uppsala, Sweden) Suzanne Van Asten (Nijmegen, Netherlands) Educational Session Dafna Yahav (Ramat-Gan, Israel) A hard nut to crack in HIV Chairs Yoav Keynan (Winnipeg, Canada) Justyna Kowalska (Warsaw, Poland) Co-organised with: ESCMID Education Subcommittee"
EW004,6,W0013,08:30,"Viral reservoir: what a physician should knowIvailo 08:30 10:30 Alexiev (Sofia, Bulgaria) Educational Session W0014 08:50 Non-suppressible viraemia during HIV-1 therapy: a challenge for cliniciansJose Arribas (Madrid, Spain) Surgical site infections: principles and practice in the era of multidrug"
EW004,6,W0015,09:10,"Chronic vascular and pulmonary disease and HIV: resistance what can we do about it?Susanne Dam Poulsen Chairs Gabriel Birgand (Nantes, France) (Copenhagen, Denmark) Efthymia Giannitsioti (Athens, Greece)"
EW004,6,W0016,09:30,"Opportunistic infections: most common and most deadlyMilena Stevanovikj (Sopje, North Macedonia, Republic of)"
EW004,6,W0001,08:30,"Evolving antimicrobial resistance: do we need a Co-organised with: Euroguidelines in Central and Eastern Europe Network change in surgical antimicrobial prophylaxis?Camilla Group Rodrigues (Mumbai, India)"
EW004,6,W0002,08:50,"Role of decolonisation and bowel decontamination in regions of overwhelming multidrug EW005 - Hall 8 08:30 10:30 resistancePrasannakumar Palanikumar (Vellore, India) Educational Session"
EW004,6,W0003,09:10,"Screening for MDR GNR coloniSation: is there Diagnostic parasitology in the XXIst century: is microscopy “+” still useful? evidence for prophylaxisElisabeth Presterl (Vienna, Austria) Chairs Miriam José Álvarez-Martínez (Barcelona, Spain) Caroline Rönnberg (Stockholm, Sweden)"
EW004,6,W0004,09:30,"Perioperative prophylaxis in special populations in the era of MDRDivyashree Shanthamurthy (Mumbai, India)"
EW004,6,W0017,08:30,"Artificial Intelligence for the diagnosis of parasitic infectionsBobbi Pritt (Rochester, United States) EW002 08:30 - 10:30 Hall 3"
EW002,3,W0018,08:50,"Histopathology of parasitic infectionsRichard Bradbury (Townsville, Australia) Educational Session"
EW002,3,W0019,09:10,"Molecular diagnosis vs. microscopy in the diagnosis Demystifying pharmacokinetics and population pharmacokinetics: a toolkit of parasitic infectionsSitara Sr Ajjampur (Vellore, for non-experts India) Chairs Shampa Das (Liverpool, United Kingdom) W0020 09:30 Paleoparasitology: what diagnostic tools?Ayman El- João Paulo Telles (Sao Paulo, Brazil) Badry (Cairo, Egypt) Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP)"
EW002,3,W0005,08:30,"Pharmacokinetics 101: navigating the basics for optimal dosingLinda Aulin (Leiden, Netherlands) EW006 08:30 - 10:30 Hall 9"
EW006,9,W0006,08:50,"The ABCs of population pharmacokinetic Educational Session modelsErwin Dreesen (Leuven, Belgium)"
EW006,9,W0007,09:10,"Looking into the crystal ball: exploring the fabulous Vaccine hesitancy: from issues to solutions through developing world of PK-PD simulationsVincent Aranzana-Climent communication skills (Poitiers, France) Chairs Monia Chemais (Soignies, Belgium)"
EW006,9,W0008,09:30,"Decoding population pharmacokinetic papers: Petar Velikov (Sofia, Bulgaria) interpreting, comparing and discussing resultsIris K. Minichmayr (Vienna, Austria) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG) W0021 08:30 Vaccine hesitancy and its consequencesNoni Macdonald (Halifax, Canada)"
EW006,9,W0022,08:50,Why are patients and parents hesitant about
EW006,9,W0023,09:10,"Using social media to deal with vaccine hesitancyMuge Cevik (St Andrews, United Kingdom)"
EW006,9,W0024,09:30,"Strengthening vaccine confidence in patients and Co-organised with: ESCMID Study Group for Implant-associated Infections parentsTba (ESGIAI), ESCMID Study Group for Mycobacterial Infections (ESGMYC) Co-organised with: ESCMID Vaccine Study Group (EVASG)"
EW006,9,M0035,11:00,"Kimberly Fornace (Singapore, Singapore) Blin Nagavci (Gjakove, Kosovo) Mical Paul (Haifa, Israel) M0036 11:12 Rachel Lowe (Barcelona, Spain) Luigia Scudeller (Pavia, Italy)"
ME007,2,M0025,11:00,"Tommaso Giani (Florence, Italy)"
ME007,2,M0026,11:12,"Diaz Lorena (Santiago, Chile)"
ME007,2,M0037,13:30,"Marjan Wouthuyzen-Bakker (Groningen, Netherlands)"
ME007,2,M0027,11:00,"Julie Toubiana (Paris, France) M0038 13:42 Trisha Peel (Melbourne, Australia)"
ME007,2,M0028,11:12,"Sanjay Patel (Winchester, United Kingdom) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Implant-associated Infections (ESGIAI), ESCMID Study Group for Infectious Diseases of the Brain (ESGIB)"
ME007,2,M0029,11:00,"Kushlani Jayatilleke (Battaramulla, Sri Lanka)"
ME007,2,M0030,11:12,"Walter Zingg (Zurich, Switzerland) M0039 13:30 Laura Evans (Seattle, United States)"
ME007,2,M0040,13:42,"Evangelos Giamarellos-Bourboulis (Athens, Greece) Co-organised with: ESCMID Study Group for Bloodstream Infections,"
ME010,6,M0031,11:00,"Ecaterina Noroc (Chisinau, Moldova, Republic of)"
ME010,6,M0032,11:12,"Fakhriddin Nizamov (Almaty, Kazakhstan) Co-organised with: Euroguidelines in Central and Eastern Europe Network Group, United Nations International Children's Emergency Fund (UNICEF) M0041 13:30 Teymur Noori (Stockholm, Sweden)"
ME010,6,M0042,13:42,"Milosz Parczewski (Szczecin, Poland) Co-organised with: European AIDS Clinical Society (EACS)"
ME010,6,M0033,11:00,"Jaime Esteban (Madrid, Spain)"
ME010,6,M0034,11:12,"Philippe Morand (Paris, France)"
ME010,6,M0043,13:30,"Daria Podlekareva (Copenhagen, Denmark)"
ME010,6,M0044,13:42,"Raquel Duarte (Porto, Portugal) Co-organised with: European Respiratory Society (ERS) M0053 14:45 Luigia Scudeller (Pavia, Italy)"
ME010,6,M0054,14:57,"Blin Nagavci (Gjakove, Kosovo)"
ME010,6,M0045,13:30,"Christina Rolfheim-Bye (Oslo, Norway) for success?"
ME010,6,M0046,13:42,"Marius Gilbert (Brussels, Belgium) Co-organised with: ESCMID Study Group for Public Health Microbiology (ESGPHM) M0055 14:45 Natividad Benito (Barcelona, Spain)"
ME010,6,M0056,14:57,"Tiziana Ascione (Naples, Italy)"
ME010,6,M0047,13:30,"Michelle Yong (Melbourne, Australia)"
ME010,6,M0048,13:42,"Genovefa Papanicolaou (New York, United States)"
ME010,6,M0057,14:45,"Tinja Laaveri (Helsinki, Finland)"
ME010,6,M0058,14:57,"David Tribble (Bethesda, United States)"
ME024,9,M0059,14:45,"Jordi Riera (Barcelona, Spain) Jesús Rodríguez-Baño (Seville, Spain)"
ME024,9,M0060,14:57,"Giacomo Grasselli (Besana In Brianza, Italy) Co-organised with: European Extracorporeal Life Support Organization (EuroELSO) Co-organised with: ESCMID Education Subcommittee"
ME024,9,M0049,14:45,"Diederik Van De Beek (Amsterdam, Netherlands)"
ME024,9,M0050,14:57,"Alexandra Mailles (Paris, France) Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain Co-organised with: ESCMID Education Subcommittee (ESGIB)"
ME024,9,M0051,14:45,"Aycan Gundogdu (Kayseri, Türkiye) W0061 16:15 The essentials of GRAM project: data sources, methodology and challenges in estimating AMR"
ME024,9,M0052,14:57,"Niranjan Nagarajan (Singapore, Singapore) burdenAuthia Gray (Washington, United States) Co-organised with: ESCMID Study Group for Host and Microbiota Interaction"
ME024,9,W0062,16:35,"Networks for surveillance of AMR in animal (ESGHAMI) pathogensLucie Collineau (Lyon, France)"
ME024,9,W0063,16:55,Transition to genomic-based methodology for
ME024,9,W0064,17:15,Implementing and running hospital-wide genomic How to make sense out of guidelines and scientific evidence surveillance of pathogensAlexander Mellmann
ME024,9,W0077,16:15,"The impact of diabetes and host-pathogen interaction and gut microbiomeReinout Van Crevel (Nijmegen,"
EW026,3,W0078,16:35,"Diabetes and invasive fungal infectionsJochem Buil (Nijmegen, Netherlands) New insights into antifungal agents and resistance W0079 16:55 Viral infections and diabetes: is there a Chairs Anuradha Chowdhary (New Delhi, India) connection?Malin Flodström-Tullberg (Stockholm, Jon Salmanton-Garcia (Cologne, Germany) Sweden)"
EW026,3,W0080,17:15,Pathogenesis of diabetic wound infectionTba
EW026,3,W0065,16:15,Emerging resistance in Candida tropicalisSharon
EW026,3,W0066,16:35,"Mechanisms of resistance in Candida glabrataDavid Educational Session Perlin (Nutley, United States)"
EW026,3,W0067,16:55,"Surveillance of resistance in Aspergillus Primer on infection prevention and control: the crucial support by clinical speciesMaiken Cavling Arendrup (Copenhagen, microbiology Denmark) Chairs Nico Tom Mutters (Bonn, Germany) Margreet C. Vos (Rotterdam, Netherlands)"
EW026,3,W0068,17:15,"Environmental surveillance for antifungal resistanceEveline Snelders (Wageningen, Netherlands)"
EW026,3,W0081,16:15,Microbial fundamentals: building blocks of infection prevention and controlLaurence Armand-Lefevre
EW027,5,W0082,16:35,"Optimising environmental sampling in infection control: rational use of the microbiology Going Viral! Phage Therapy Clinical rounds laboratoryJohn E. Coia (Esbjerg, Denmark) Chairs Gregory German (Maple, Canada) W0083 16:55 The crucial role of molecular typing in infection Ameneh Khatami (Sydney, Australia) controlStefanie Kampmeier (Würzburg, Germany)"
EW027,5,W0084,17:15,"How can we link diagnostic and antibiotic stewardship?Constantinos Tsioutis (Nicosia, Cyprus)"
EW027,5,W0069,16:15,"Clinical cases and lessons from the STAMP Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), protocolHolly Sinclair (Nsw, Australia) EUCIC Steering Committee"
EW027,5,W0070,16:35,"Difficult cases treated with phagesGhady Haidar (Pittsburgh, United States)"
EW027,5,W0071,16:55,"Challenging osteoarticular cases treated with phagesTristan Ferry (Lyon, France)"
EW027,5,W0072,17:15,"Treating urinary tract infections with phages: dream or reality?Saima Aslam (San Diego, United States) SY036 - Hall 15 08:30 10:30 Co-organised with: ESCMID Study Group for Non-traditional Antibacterial Therapy (ESGNTA) 2-hour Symposium The quality of antibiotics used in the communities of LMICs"
EW027,5,S0105,08:30,"The quality of antibiotics and their potential impact on patient outcome and AMRPaul Newton (Oxford, Chairs Maddalena Giannella (Bologna, Italy) United Kingdom) Asma Nasim (Karachi, Pakistan)"
EW027,5,S0106,09:00,"Community antibiotic access and use in Sub-Sahara AfricaSamuel Afari-Asiedu (Kintampo, Ghana)"
EW027,5,S0107,09:30,Encountered challenges and reflections on
EW027,5,W0073,16:15,"Challenges in managing gastrointestinal infections in conducting multi-country medicine quality patients with primary immunodeficiencyEffrossyni studiesNoudy Sengxeu (Vientiane Capital, Lao Gkrania-Klotsas (Cambridge, United Kingdom) People's democratic republic)"
EW027,5,W0074,16:35,Respiratory infections in patients receiving CAR-T
EW027,5,S0108,10:00,"Confusion in appearance of common used antibiotics cells or bispecific monoclonal antibodiesGemma in LMICsHeiman Wertheim (Nijmegen, Netherlands) Reynolds (Heidelberg, Australia)"
EW027,5,W0075,16:55,"Mycobacterial infections in patients with HIV infectionGraeme Ayton Meintjes (Observatory, South SY031 - Hall 6 08:30 10:30 Africa)"
EW027,5,W0076,17:15,"Breakthrough fungal infections in haematopoietic 2-hour Symposium cancer and in stem cell transplantationDimitrios P. Kontoyiannis (Houston, Tx, United States) To screen or not to screen prior to transplant? Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), Chairs Laura Alicia Barcan (Buenos Aires, Argentina) International Immunocompromised Host Society (ICHS) Oscar Len (Barcelona, Spain)"
EW029,8,S0085,08:30,"HHV-8 ScreeningAlessandra Mularoni (Palermo, Italy) Educational Session"
EW029,8,S0086,09:00,"TB screening and prevention in endemic Impact of diabetes on infectious diseases: what should we know? regionsRubina Naqvi (Karachi, Pakistan)"
EW029,8,S0087,09:30,"Screening for and prevention of chagas in response to antibiotics in a dual-species intracellular immunocompromised hostsMarcelo Victor Radisic infection modelF. Van Bambeke* (Brussels, Belgium), (Buenos Aires, Argentina) G. Wang"
EW029,8,S0088,10:00,"Screening of lung donors for MolicutesMichael G Ison E0031 In vitro investigations of ceftazidime-avibactam and (Derwood (MD), United States) fosfomycin against carbapenemase-producing Enterobacterales clinical isolatesM. Martens* (Hamburg, Germany), F.M. Docobo-Perez, C. Sauco"
EW029,8,S0097,08:30,"Should we be concerned about infection from virus of the infant population in Sibiu county, contaminated endoscopes?Claire Aumeran RomaniaS. Cristea* (Sibiu, Romania), C. Grigore (Clermont-Ferrand, France)"
EW029,8,S0098,09:00,Prevention of multidrug-resistant infections from contaminated duodenoscopesMargreet C. Vos
EW029,8,S0099,09:30,"Understanding the causes of medical device ePoster Flash Session contamination: it is all biofilm!Roberto Rusconi (Milan, Italy) Pharmacology from bench to the bedside"
EW029,8,S0100,10:00,"Does the European medical Device Regulation bring Chair Alina Karoline Nussbaumer-Pröll (Wien, Österreich, us safer duodenoscopes?Markus Hell (Salzburg, Austria) Austria) Co-organised with: ESCMID Study Group for Biofilms (ESGB), ESCMID Study Group for Nosocomial Infections (ESGNI)"
EW029,8,S0103,09:30,"Integration of HIV and TB care to improve patient outcome in resource-limited settingsAkaki Abutidze Translating metagenomics into clinical practice (Tbilisi, Georgia) Chairs Benjamin Peter Howden (Parkville (Victoria),"
EW029,8,S0104,10:00,"How researchers can influence policy and practice in Australia) HIV/TB careJens D. Lundgren (Copenhagen, Paula Mölling (Örebro, Sweden) Denmark) Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), Euroguidelines in Central and Eastern Europe Network Group"
EW029,8,W0126,08:30,"Costs of RSV infection, compared to other (London, United Kingdom), A. Kopec, J. Brown, J. respiratory virusesBarbara Rath (Besançon, France) Hatcher, A. Alcolea-Medina, R. Batra, D. Ward, L.B. Snell, J. Breuer W0127 08:50 Virology and host interactions of RSV"
EW029,8,W0128,09:10,"RSV surveillance in the EU/EEA in the vaccine metagenomic next-generation sequencing in ICU eraEeva Broberg (Solna, Sweden) patients with ongoing antibiotic therapyT. W0129 09:30 RSV fusion inhibitors and monoclonals: current Schroeder* (Nuertingen, Germany), M. Eliwi Alsaffan, status and future developmentsPeter Openshaw A. Dervishi, P. Kawaletz, H. Stäudle (London, United Kingdom)"
EW029,8,W0130,08:30,"Multidrug-resistant infections after trauma in warzoneShehan Hettiaratchy (Hampton, United"
EW029,8,W0131,08:50,"Fungal infections during natural disastersAnuradha lower respiratory tract infections in ICUB. Ran* Chowdhary (New Delhi, India) (Taiyuan, China), Y. Liu, X. Wu, X. Lin, X. Li, Q. Zhan, C. W0132 09:10 Bacteriophage therapy for multidrug-resistant wound Wang, L. Huang, T. Zhai, Y. Cai, Y. Song, Q. Zhang, C. infections in traumaTristan Ferry (Lyon, France) Zhang, J. Hao, L. Jin, Z. Huang"
EW029,8,W0133,09:30,"Infection of burn woundsNur Benzonana (Istanbul,"
EW029,8,S0109,08:30,"Source of infection and pathogensChristian Eckmann 08:30 10:30 (Hannover, Germany) 2-hour Symposium S0110 09:00 Prophylaxis and empiric treatmentGiacomo Grasselli (Besana In Brianza, Italy) Barriers to TB/HIV elimination in low- and high-incidence settings"
EW029,8,S0111,09:30,"Diagnostic criteria and definitionsGraeme Maclaren Chair Daria Podlekareva (Copenhagen, Denmark) (Singapore, Singapore)"
EW029,8,S0112,10:00,"Microbial filmsMarta Hernández-Meneses (Barcelona, Spain)"
EW029,8,S0101,08:30,"HIV and TB epidemic: the storm hasn’t subsided Co-organised with: European Extracorporeal Life Support Organization yetTetiana Koval (Poltava, Ukraine) (EuroELSO)"
EW029,8,S0102,09:00,Approaches for latent and active TB screening in
EW029,8,W0118,08:30,"Update on paediatric UTI Michael Buettcher (Luzern, J.S. Lee, N.S.B. Haidi Fitri, Z.X. Tan, X. Huan, N.M. Switzerland) Thevasagayam, T.K.B. Lee, K. Marimuthu, O.T. Ng"
EW029,8,W0119,08:50,"Diagnosis and treatment of UTI in the era of O0003 Deciphering the pathogenic potentials and antimicrobial resistanceJennifer Kranz (Aachen, epidemiological identities of Staphylococcus Germany) pseudintermedius colonizing companion dogs in Sao PauloI.B. Moses* (Sao Paulo, Brazil), L. Sartori,"
EW029,8,W0120,09:10,"Can UTI be prevented?Chris Harding (Newcastle D.A. Henriques, M.M. Marini, F.M. Lima, R.X. Upon Tyne, United Kingdom) Espinosa, I. Orlandino Da Silva, F.F. Santos, L."
EW029,8,W0121,09:30,"Fungal and parasitic infections of the urinary Gonzaga, A.T. Ribeiro De Vasconcelos, A.C. Gales tractGladys Mbwanji (Mwanza, Tanzania, United"
EW040,3,W0122,08:30,"OPAT: principles, practice and checklistsCharlotte Kingdom), A. Pondit, J. Parkhill, S. Saha, S.M.R. Quintens (Leuven, Belgium) Islam, P.I. Disha, S.A. Nasreen, M.A.K. Azad, T."
EW040,3,W0123,08:50,"COPAT: complex outpatient parenteral antimicrobial Walsh, R. Farzana therapy Ronald Andrew Seaton (Glasgow, United O0007 Unveiling the invisible: antimicrobial resistance Kingdom) genes and pathogenic microbial diversity in sewage"
EW040,3,W0124,09:10,"Antimicrobial stability and other challenges for OPAT of North India's largest industrial hub, A practice? Mark Gilchrist (London, United Kingdom) metagenomic perspectiveI. Singh* (Chandigarh, India), R. Sharma, A. Arora, B. Mohan, N. Taneja"
EW040,3,W0125,09:30,"New OPAT safety and efficacy data to guide practiceMatthew Rawlins (Murdoch, Australia) O0008 Culturomics as a tool for ONE HEALTH approach: Unveiling the role of unknown microorganisms as Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), antibiotic resistance carriers in wastewater Society of Infectious Diseases Pharmacists (SIDP) samplesE. Ouranou* (Heraklion, Greece), A. Psaroulaki, D. Chochlakis, M. Malliarou, K. Tryfinopoulou, A. Ntoula, E. Intze, I. Lagouvardos EW038 08:30 - 11:30 Hall 4"
EW038,4,W0113,08:30,"EUCAST updateSören G. Gatermann (Bochum, M. Quintelas, M. Caniça, R. Rivière, P. Poeta, G. Germany) Igrejas"
EW038,4,W0114,08:50,"Setting clinical breakpoints, assessing evidenceAnouk Edwina Muller (The Hague, Netherlands) SY032 08:30 - 10:30 Hall 7"
SY032,7,W0115,09:10,"Benzylpenicillin susceptibility testing of S. 2-hour Symposium pneumoniae by disk diffusionGunnar Kahlmeter (Tävelsås, Sweden) New insights into Candida pathogenesis"
SY032,7,W0116,09:30,"What to do when there are no breakpointsBarbara Chairs Aleksandra Barac (Belgrade, Serbia) Juliane Holzknecht (Copenhagen, Denmark) Joshua Nosanchuk (Bronx, United States)"
SY032,7,W0117,09:50,"Detection of resistance mechanismsChristian Giske (Stockholm, Sweden) Co-organised with: EUCAST Steering Committee"
SY032,7,S0089,08:30,"Insights into the evolution of Candida under antifungal pressureAttila Gacser (Szeged, Hungary)"
SY032,7,S0090,09:00,How do Candida extracellular vesicles modify
SY032,7,S0091,09:30,"The commensal to pathogen transition: kind to One Health means resistance everywhere killerIlse D. Jacobsen (Jena, Germany) Chairs Alessandra Carattoli (Rome, Italy) S0092 10:00 Fungal-bacterial interactions: who wins?Rebecca Hall Prasannakumar Palanikumar (Vellore, India) (Canterbury, United Kingdom)"
SY032,7,S0093,08:30,"Adaptive evolution and phenotypic heterogeneity of bacterial pathogens during infectionsChristoph Ernst Emerging developments in antifungal pharmacology (Cologne, Germany) Chair Roger Brüggemann (Nijmegen, Netherlands)"
SY032,7,S0094,09:00,"Single-cell imaging and heterogeneity in antimicrobial resistanceStefano Pagliara (Exeter, United Kingdom)"
SY032,7,S0095,09:30,"Single-cell RNAseq and heterogeneity in bacterial E0048 NATURE-US: the natural history of antifungal failure transcriptionAnna Kuchina (Seattle, United States) in invasive candidiasisL. Ostrosky-Zeichner*"
SY032,7,S0096,10:00,"Dissecting the function of individual bacteria in their (Houston, United States), P.G. Pappas, M.H. Miceli, spatial contextKnut Drescher (Basel, Switzerland) A. Spec, C.Z. Grimes, F. Lewis, M. Mammadova, E. McKie, M. Middle, M. Kordalewska, D.S. Perlin, D.P. Kontoyiannis, O.A. Cornely, J. Vazquez, D. Angulo"
SY043,1,S0134,09:30,"Andrew James Stewardson (Melbourne, Victoria, albicans through a drug repurposing strategyD. Australia) Marques* (Lisbon, Portugal), S. Santos Costa, L. Rodrigues"
SY043,1,S0135,10:00,"Kalisvar Marimuthu (Singapore, Singapore)"
FO050,,F0147,11:00,"HIV, from key population to general population: a Japan), Y. Kawamoto, K. Yanagihara Pandora's BoxSyed Faisal Mahmood (Karachi,"
FO050,,F0148,11:10,"Ethical considerations in preventing mother-to-child bloodstream infectionsL. Van Balen* (Maastricht, HIV transmission Glory Alexander (Bangalore, India) Netherlands), R. Koeck"
FO050,,F0149,11:20,HIV drug trials in Africa: ethical concernsShah Reena
FO050,,F0150,11:30,"HIV-related stigma and discrimination in the E0100 Nanopore long-read only genome assembly for public healthcare settingTeymur Noori (Stockholm, health surveillance of Enterobacterales bloodstream Sweden) infections and plasmid epidemiology in England: A Co-organised with: ESCMID Ethics Advisory Committee (EEAC) pilot studyD. Nagy* (Oxford, United Kingdom), N. Stoesser, S. Lipworth, V. Pennetta, G. Rodger, K. Hopkins, C. Jones, T. Neksus Study Group, S. Hopkins, D. Crook, A.S. Walker, J. Robotham, K.L."
SY047,11,S0141,11:00,"Contact isolation in patients with MDR organisms: Mulè, L. Denti, M. Puoti, R. Rossotti Why, when, where?Gabriel Birgand (Nantes, France)"
SY047,11,S0142,11:30,"Is discontinuation of contact precautions associated emerging threat to public health?J. Ciscar Soriano* with an increase in infections?Daniel Diekema (València, Spain), J. Ciscar-Soriano, M.D. Gómez- (Harpswell, United States) Ruiz, A. Valentín-Martín, A. Hernández-Cabezas, Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), J.L. Lopez-Hontangas EUCIC Steering Committee, Multidisciplinary Joint Committee Infection"
SY047,11,M0143,11:00,"Etienne Ruppe (Paris, France) Singapore), A.L. Tan, B.K.W. Yeo, M.T.W. Chio, S.S. Goh, S.T. Koh, Y.E. Tan M0144 11:12 Stefan Green (Chicago, United States)"
ME049,14,M0145,11:00,"Monica Slavin (Melbourne, Australia) 1-hour Symposium"
ME049,14,M0146,11:12,"Nkechi Azie (Barrington, United States) What happens following TB infection? Co-organised with: ESCMID Fungal Infection Study Group (EFISG) Chairs Catherine Ong (Singapore, Singapore) Sean Wasserman (London, United Kingdom)"
ME049,14,S0137,11:00,"Post-TB disease: burden and treatment strategiesDeborah Chong (London, United Kingdom) Climate Impact and One Health Approaches Against Infectious Diseases"
ME049,14,S0138,11:30,"TB sequelae and fungal infectionHelmut Salzer (Linz, Chair Chadia Wannous (Paris, France) Austria) Co-organised with: ESCMID Study Group for Mycobacterial Infections (ESGMYC), CPAnet"
SY046,5,S0139,11:00,"Bacterial infections and cellular immunityCharlotte strategy guided by post-transplant CMV-specific cell- Odendall (London, United Kingdom) mediated immunity in intermediate-risk kidney transplant recipientsI. Rodríguez-Goncer* (Madrid, S0140 11:20 Immuno-metabolism in bacterial diseasesTania Wong Spain), J.M. Caso, M. Fernández-Ruiz, E. González, N. (New York, United States) Polanco, N. Redondo, T. Ruiz-Merlo, R. San-Juan, L.M. Allende, E. Paz-Artal, A. Andrés, F. López- Medrano, J.M. Aguado, I. Rodríguez-Góncer OS007 11:00 - 12:00 Hall 6"
SY051,1,S0151,13:30,"Yoav Keynan (Winnipeg, Canada) Spain), O. Martín, A. Romero-Alegría, M. Belhassen, S0152 14:00 Elisa Cordero Matia (Seville, Spain) S. Chamorro Tojeiro, D. Gayoso Cantero, F. Norman, B. Monge Maillo, C. Crespillo-Andújar, M.D."
SY051,1,S0155,13:30,"The PROs and CONs of using AI tools for developing allogeneic hematopoietic cell transplant (HCT) guidelinesHolger Schuenemann (Milano, Italy) recipientsS. De Aragón De La Cruz* (Basel,"
SY051,1,S0156,14:00,"AI in action: validated tools for speeding up your Switzerland), C.S. Walti, N. Khanna, K. Leuzinger, systematic reviews and how to use themSara J.P. Halter, H.H. Hirsch, K. Nägele, J. Passweg, J. Fernandez (Oslo, Norway) Vosbeck Co-organised with: ESCMID Guidelines Subcommittee E0147 Real-life experience with maribavir for the treatment of cytomegalovirus infection in hematological patients.J. Boan Perez* (Madrid,"
EF022,,S0153,13:30,"Are children really super-spreaders of respiratory Syndromic testing is still coming of age viruses?Emmanuel André (Leuven, Belgium) Chair Tommaso Giani (Florence, Italy)"
EF022,,S0154,14:00,"Should schools be closed at the start of the next pandemic?Vittoria Colizza (Paris, France) Co-organised with: European Society of Paedriatic Infectious Diseases E0148 Bacterial infections of the central nervous system: (ESPID) addressing the diagnostic gap in non- community- acquired meningitisG. Menchinelli* (Rome, Italy), M. Cacaci, D. Squitieri, B. Fiori, T. D'inzeo, G. De Angelis,"
EF024,,M0157,13:30,"Hans Steenackers (Leuven, Belgium) Saiz-Escobedo, J. Guerrero, E. Cuevas, D. Guevara- M0158 13:42 Brian Conlon (Chapel Hill, United States) Nuñez, F. Tubau, J. Burgos, M. Lopez, A. González- Díaz, C. Ardanuy, M. Dominguez, S. Santos, S. Martí"
EF024,,M0159,13:30,"Monica Gandhi (Salt Lake City, United States) C. Torti"
EF024,,M0160,13:42,"Pedro Cahn (Buenos Aires, Argentina)"
OS020,15,M0170,14:45,"Javier Fernández (Oviedo, Spain) Kingdom), K. Pouwels, J.V. Robotham, S. Yu, S. Wordsworth M0171 14:57 Nicolas Radomski (Teramo, Italy)"
OS020,15,F0174,14:45,"The ID:IOTS guide to creating a successful CM/ID Mehta, M.L. Brito Ferreira, C. Soares, R. Medialdea podcast""Callum Mutch (Edinburgh, United Kingdom) Carrera, M. Tulius, P. Brasil, C. Miguelote, A."
OS020,15,F0175,14:55,"Using social media for CM/ID educationScott Jake Henriques Souza, M. Ellul, M. Griffiths, M.M. Jardim (Oakland, United States) Rodrigues, R. Braga, L. Pamplona, C. Spitz, F. Militao, A. Rosala Hallas, G. Burnside, R. Vivancos,"
OS020,15,F0176,15:05,"Podcasting and social media for antimicrobial S. Leonhard, L. Rodrigues De Mendonça-Vieira, B. stewardship and pharmacyErin Mccreary Jacobs, C. Brito, P. Sequiera, D. Brown, L. Turtle, R. (Pittsburgh, United States) Franca, A. Bispo, T. Solomon Co-organised with: CMI Communications Board of Editors"
KN056,1,S0166,14:45,"Pro: clinical benefit and potential for improved patient combination(CSE) as a treatment option for outcomesKirstine K. Søgaard (Aalborg, Denmark) carbapenem resistant gram negative bacilli - to be or not to be?Y. Verma* (Hisar, India), K. Narang, D. S0167 15:15 Con: limitations, costs, and possible overuse of Bandlish, C. Sharma syndromic panelsGilbert Greub (Lausanne, Switzerland)"
KN056,1,S0168,14:45,"Infection risks from sanitation engineeringDavey Pseudomonas aeruginosa with in vitro-guided Jones (Bangor, United Kingdom) combination antibiotic therapyJ. Teo* (Singapore, Singapore), J.H. Toh, H.Y. Chang, S.H. Tan, W. Lee, S0169 15:15 Ventilation in toilets: how can we improve it?Michael T.P. Lim, Y.E. Tan, S.J. Chung, A.L.H. Kwa Gormley (Edinburgh, United Kingdom)"
KN056,1,M0172,14:45,"Claire Roger (Nimes, France) The rare art of writing scientific articles: from conception to submission"
KN056,1,M0173,14:57,"Isabel Spriet (Leuven, Belgium) Chairs Marlieke De Kraker (Geneva, Switzerland) Mical Paul (Haifa, Israel) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG), ESCMID Study Group for Critically Ill Patients (ESGCIP)"
KN056,1,W0205,16:15,Expressing yourself correctly: writing tipsAngela
SY057,2,W0206,16:35,"Constructing your manuscript for an original 1-hour Symposium articleJesús Rodríguez-Baño (Seville, Spain) Macrolides in community-acquired pneumonia: therapeutic necessity or path W0207 16:55 The use of artificial intelligence tools for writing to overuse? articles: what to do and not to doErlangga Yusuf (Rotterdam, Netherlands) Chairs Marc J.M. Bonten (Utrecht, Netherlands) Karin Thursky (Carlton, Australia) W0208 17:15 Selecting the best journal for my manuscriptAndre Kalil (Omaha, United States) Co-organised with: CMI Board of Editors"
SY057,2,S0162,14:45,"Pro: maximising outcomes with evidence-based useEvangelos Giamarellos-Bourboulis (Athens, Greece) SY069 16:15 - 18:15 Hall 16"
SY069,16,S0163,15:15,"Con: the risks of routine (over)useAurélien Dinh 2-hour Symposium (Garches, France) Controlled human infection models Chairs Frederick Hayden (Charlottesville, United States)"
SY069,16,S0197,16:15,"Updates on the dengue human infection Chairs Nicolas Mueller (Zurich, Switzerland) modelKirsten Lyke (Baltimore, United States) Alessandra Mularoni (Palermo, Italy) S0198 16:45 CHIM in endemic countriesMelissa Kapulu (Kilifi, Kenya)"
SY069,16,S0199,17:15,Controlled human infection models of parasitic
SY069,16,S0164,14:45,"Top 10 papers in infections in SOTPatricia Munoz infectionsMeta Roestenberg (Leiden, Netherlands) (Madrid, Spain) S0200 17:45 Controlled human infection models of non-typhoidal"
SY069,16,S0165,15:15,"Top 10 paper in infections in HCT and cellular SalmonellaMalick Gibani (London, United Kingdom) therapyJoshua Hill (Seattle, United States) Co-organised with: British Infection Association (BIA)"
SY067,11,S0189,16:15,STI treatment options are running out due to
SY067,11,S0190,16:45,"Genomic surveillance of Neisseria gonorrhoeae causing fungaemia in patients admitted to a tertiary strainsPetra Wolffs (Maastricht, Netherlands) hospital in Madrid from 2014 to 2024J. Guinea* (Madrid, Spain), P. Escribano, A. Gomez, A. Burillo, S0191 17:15 Evolutionary insights into syphilis and Treponema P. Muñoz pallidumMathew Beale (Hinxton, United Kingdom)"
SY067,11,S0192,17:45,"Challenges in chlamydial STI infectionsCecile Bebear Similar Across BodyweightR.E. Wrishko* (Rahway, (Bordeaux, France) United States), P. Kothare, T.J. Bateman, M.G. Co-organised with: Deutsche Gesellschaft für Hygiene und Mikrobiologie Johnson, A. Stoch"
SY068,12,S0193,16:15,"Tick-borne encephalitis: immune response and P. Rhomberg, M. Castanheira clinical experienceSara Gredmark Russ (Stockholm,"
SY068,12,S0194,16:45,"TBE immune responses and vaccine Aviv, Israel), R. Shadhan, A. Novikov, N. Mizrahi effectivenessKarin Stiasny (Vienna, Austria)"
SY068,12,S0195,17:15,"NS1 antibodies: diagnostics and screening of clinical isolates collected as part as two national seroprevalence of TBE virus infectionGerhard surveys on azole resistance conducted in Spain Dobler (Munich, Germany) (ASPEIN II and III)J. Guinea* (Madrid, Spain), P. Escribano, J. Moraga, A. Gomez, P. Muñoz S0196 17:45 Treatment for TBE: where do we stand?Daniel Ruzek (Brno, Czech Republic)"
SY068,12,L0031,16:15,"Introduction, Julia Anna Bielicki (London, United SPICMI, FranceP. Astagneau* (Paris, France), B. Kingdom), Vance Fowler (Durham, United States) Nkoumazok, N. Benhajkassen, I. Arnaud, D. Verjat-"
SY068,12,L0032,16:20,"Description of SNAP trial Trannoy, J. Auraix, K. Lebascle"
SY068,12,L0033,16:30,Benzylpenicillin versus (flu)cloxacillin for the
SY068,12,L0034,16:45,Cefazolin versus (flu)cloxacillin for the treatment of
SY068,12,L0035,17:00,"Cloxacillin versus cefazolin for methicillin-susceptible Bernatoniene, S. Bhowmik, J. Perry, P. Mottram, P. Staphylococcus aureus bacteraemia (CloCeBa): a Mcnamara, D. Lewis, N. Van Kinnekan, A. Finn randomised, controlled, non-inferiority trialX. O0230 Targeted metagenomic sequencing of influenza, Lescure* (Paris, France), F. Vandenesch, X. Duval, S. RSV, and symptomatic respiratory infections from Tubiana, C. Burdet, N. Saïdani, A. Lemaignien, E. UK healthcare workersM. Knoll* (Hinxton, United Canoui, L. Surgers, M. Esposito Farese, V. Le Moing, Kingdom), L. Findlater, B. Katie, J. Wagner, T. Diego, P. Tattevin D. Rajan, S. Frances Field, S. Thurston, A. Wong, B."
SY068,12,L0036,17:15,"Trial DiscussionJulia Anna Bielicki (London, United Hyatt, N. Thesin, J. Robinson, R. Yeadon, A. Galvin, Kingdom) B. Blane, Y.L. Huang, K. Howe, M. Forbes, K. Figueroa, F. Schwach, S. Stott, A. Marhino, A. Frick-"
SY068,12,L0037,17:30,"Trial DiscussionVance Fowler (Durham, United Kretschmer, B. Dave, T. Maddison, S. Hopkins, S. States) Foulkes, J. Islam, A. Atti, V. Hall, E. Harrison"
SY068,12,L0038,17:45,Open Discussion and Q&A
SY064,2,S0177,16:15,PK/PD and antibacterial therapyDolors Soy-Muner
SY064,2,S0178,16:45,"PK/PD and antifungal therapyRoger Brüggemann influenza infections over ten years in FranceP. (Nijmegen, Netherlands) Loubet* (Nimes, France), S. Guitton, R. Simon, L. Lefrancois, L.B. Luong Nguyen, P. Vanhems, F. S0179 17:15 PK/PD and antiviral therapyJoe Standing (London, Laine, F. Galtier, X. Duval, B. Lina, M. Valette, G. United Kingdom) Lagathu, V. Foulogne, N. Houhou-Fidhou, A.S."
SY064,2,S0180,17:45,"PK/PD considerations in anthelminthic L'honneur, F. Carrat, L. Meyer, C. Durier, O. Launay treatmentJennifer Keiser (Allschwil, Switzerland)"
SY064,2,W0201,16:15,"Malaria in the non-endemic setting: who to treat as Observational Real-world Study in FranceS. an outpatient and how to detect treatment Fourati* (Créteil, France), A. Reslan, J. Bourret, Y. failureEmmanuel Bottieau (Antwerp, Belgium) Rahou, L. Chollet, S. Pillet, P. Tremeaux, N. Candace Dossou, E. Gault, M. Salmona, B.M. Imbert, A. W0202 16:35 Malaria resistance mutations in the non-endemic Mirand, S. Larrat, A. Moisan, S. Marot, A. setting: role of genomic surveillanceAnna Rosanas Schnuriger, N. Veyrenche, I. Engelmann, L. Handala, Urgell (Antwerp, Belgium) A. Henry, V. Stephan, S. Brichler, V. Avettand- W0203 16:55 How to manage Plasmodium Knowlesi infectionGiri Fenoel, N. Zemali, C. Lefeuvre, C. Pronier, L. Shan Rajahram (Kota Kinabalu, Malaysia) Deroche, M.C. Jaffar, L. Mouna, C. François, A."
SY064,2,W0204,17:15,"Epidemiology and control of Plasmodium Regueme, C. Hartard, S. Roger, F. Gallais, A. Ly, C. KnowlesiKimberly Fornace (Singapore, Singapore) Rodriguez, G. Dos Santos, J. Buchrieser, O. Schwartz, J.M. Pawlotsky, F. Lemoine, E. Audureau, Co-organised with: British Infection Association (BIA) M.A. Rameix-Welti"
SY065,4,S0181,16:15,"The vanco chronicles: enterococci's global Chiew, B. Ong, D. Lye journeyGuido Werner (Wernigerode, Germany)"
SY065,4,S0182,16:45,"Pitfall in susceptibility testing of Gram- syncytial virus in adults with acute respiratory positivesHelena Zemlickova (Prague, Czech infections – a Danish nationwide cohort Republic) studyStanislava Bratkovic (Copenhagen, Denmark)"
SY065,4,S0183,17:15,Drivers for daptomycin and linezolid resistance in
SY065,4,S0184,17:45,"What is new in treatment against MDR Gram- tertiary care in England: report from the STOP RSV positives?Alex Soriano (Barcelona, Spain) prospective surveillance studyE. Carter* (Liverpool, United Kingdom), H. Hill, D. Ferreira, A. Collins, C. Solórzano, L. Mclellan, L. Kerruish, F. Fyles, S. Drysdale, P. Gonzalez-Dias, G. Duncan, K. Davies, P. SY066 16:15 - 18:15 Hall 5 Crozier, P. Saunderson, R. Kramer, M. Bangert, N. Vassilouthis, S. Messahel, B. Caroline, S. Brearey, J. 2-hour Symposium"
SY066,5,S0185,16:15,"The Vietnamese experience with CRP testing in the A.P. Rodriguez Zulueta community settingThi Thuy Nga Do (Ha Noi, Vietnam) E0260 Acute disseminated encephalomyelitis following"
SY066,5,S0186,16:45,"The Nigerian experience with CRP testing in the bacterial meningoencephalitis – Two Case reports & community settingAugustine Onwunduba (Awka, Review of LiteratureM. Priyadarshi* (Delhi, India), M. Nigeria) Salunkhe, A. Mohan, P. Gupta, A. Agarwal, V. Goel, R. Bhatia"
SY066,5,S0187,17:15,"CRP testing in diagnosing tuberculosis in Zambia and South AfricaHelen Ayles (Lusaka, Zambia) E0261 Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Patient:"
SY066,5,S0188,17:45,"The health economics of CRP testing in LMICsYoel A Case Report and Literature reviewD. Chemello* Lubell (Bangkok, Thailand) (Modena, Italy), G. Franceschi, S. Alessandra, B. Andrea, S. Mario, M. Marianna, M. Cristina"
SY066,5,S0221,08:30,Diphtheria: from clinical picture to medical
SY066,5,S0222,09:00,"The epidemiology of diphtheria worldwide over the Hospital WastewaterA.K. Bari* (Groningen, last half-century: more than one comebackAndreas Netherlands), B. Sinha, J.W.A. Rossen, B.B. Xavier, Hoefer (Solna, Sweden) T.T. Severs, M.J. Cardoso, M. Savin S0223 09:30 There’s more than one toxigenic Corynebacterium:"
SY066,5,S0224,10:00,"Diphtheria vaccination: a reappraisal Gayatri Switzerland), A.M. Rooney, S. Moser, A. Egli Amirthalingam (London, United Kingdom) Co-organised with: ESCMID Study Group for Epidemiological Markers (ESGEM), ESCMID Vaccine Study Group (EVASG)"
EW079,11,W0237,08:30,"Tuberculous meningitis: what can we learn from the novel, oral, long-acting HSV helicase-primase first global guidelines?Joseph Donovan (Ho Chi Minh inhibitor: Interim results from a Phase 1a/1b study in City, Vietnam) healthy participantsA. Gaggar* (South San W0238 08:50 WHO guidelines on bacterial meningitis: change of Francisco, United States), E. Gane, C. Schwabe, G. clinical practice?Matthijs Brouwer (Amsterdam, Wang, J. Liu, S. Knox, K. Kitrinos, K. Zomorodi Netherlands)"
EW079,11,W0239,09:10,"ESCMID encephalitis guidelines 2024: what’s dependent on treatment initiation timeL. new?Tom Solomon (Liverpool, United Kingdom) Sudarsono* (Leiden, Netherlands), X. Liu, J.G.C."
EW079,11,W0240,09:30,"WHO guidelines for cryptococcal meningitis: success Van Hasselt, A.G. Märtson stories and barriers to implementationNelesh"
EW079,11,S0213,08:30,A broad spectrum of possibilities: spectrum scores as
EW079,11,S0214,09:00,Proxy indicators to estimate appropriateness of
EW079,11,S0215,09:30,"How to bridge the gap between surveillance and López, D. López Parra, J. Llenas García antimicrobial stewardshipMark G. J. De Boer (Leiden,"
EW079,11,S0216,10:00,"Health economics, surveillance and antimicrobial with enhanced effects following treatmentAnna stewardshipZhu Nina Jiayue (London, United Mertelsmann (Zürich, Switzerland) Kingdom)"
EW079,11,S0225,08:30,"New indicators in national monitoring and evaluation Chairs Frédéric Barbut (Paris, France) of AMR supported by improved data utilisationDirek Kerrie Davies (Leeds, United Kingdom) Limmathurotsakul (Bangkok, Thailand)"
EW079,11,S0226,09:00,Interdisciplinary investigation of the drivers and burden of AMR in urinary tract infectionsStephen
EW079,11,S0217,08:30,"Severe CDI: when standard protocols failHynek Mshana (Mwanza, Tanzania, United republic of) Bartos (Prague, Czech Republic) S0227 09:30 A clinically-oriented AMR surveillance network: case-"
EW079,11,S0218,09:00,"Therapies for complicated CDIEmma Bishop (Clayton based surveillance and implementationPaul Turner Vic, Australia) (Siem Reap, Cambodia)"
EW079,11,S0219,09:30,"Recurrent CDI: Breaking the cycleAndrea Marino S0228 10:00 National prescribing guidelines based on AMR (Catania, Italy) surveillance dataVilada Chansamouth (Vientiane, Lao People's democratic republic)"
EW079,11,S0220,10:00,"Live biotherapeutic products for Clostridioides difficile infectionSimon Goldenberg (London, United Co-organised with: CAESAR network, ESCMID Study Group for Antimicrobial Kingdom) Resistance Surveillance (ESGARS) Co-organised with: ESCMID Study Group for Clostridioides difficile (ESGCD)"
OS038,14,W0229,08:30,"Differentiating acute infection, sepsis and sepsis"
OS038,14,W0230,08:50,"Machine learning for early recognition of United Kingdom), A. Gregg, Q. Liu, S. Owen, C. Chen, sepsisKarsten Borgwardt (Martinsried, Germany) M. Edward, S. Jiang, W. Lu, L. Mynheer, W. Finch W0231 09:10 How to avoid common mistakes in randomised"
OS038,14,W0232,09:30,"Improved clinical trials in community-acquired bacteriaC. Moguet* (Guipry, France), S. Oueslati, A. pneumonia using precision medicineLennie Derde Vogel, S. Gelhaye, A. Chalin, H. Volland, T. Naas (Utrecht, Netherlands)"
SY072,3,S0209,08:30,"How dengue, chikungunya and zika virus disease Ekelund, A. Van Belkum became emerging threats to EuropeCeline Gossner"
SY072,3,S0210,09:00,"Surveillance of dengue in urbanised tropical (AusDiagnostic)A. Braille* (Paris, France), M. regionsVincent Junxiong Pang (Singapore, Mainardis, F. Meunier, M. Mathar, M. Mérimèche, B. Singapore) Condamine, F. Caméléna, B. Berçot"
SY072,3,S0211,09:30,Mosquito surveillance and control: opportunities and
SY072,3,S0212,10:00,"Tracking autochthonous arboviral infectionLuisa bacteria from positive blood culturesD. Squitieri* Barzon (Padua, Italy) (Rome, Italy), G. Menchinelli, C. Magrì, T. D'inzeo, M. Cacaci, B. Posteraro, G. De Angelis, M. Sanguinetti Co-organised with: European Centre for Disease Prevention and Control (ECDC)"
EW078,4,W0233,08:30,"Is metagenomics right for my lab?Paula Mölling Chairs Kwame Ohene Buabeng (Ho, Ghana) (Örebro, Sweden) H. Rogier Van Doorn (Hanoi, Vietnam)"
EW078,4,W0234,08:50,"Understanding the experimental and certification Contemporary diagnostic approaches for fungal infections aspects of metagenomicsMads Albertsen (Aalborg, Chair Ilse D. Jacobsen (Jena, Germany) Denmark)"
EW078,4,W0235,09:10,"Navigating tools, techniques, and procurementBasil Britto Xavier (Groningen, Netherlands)"
EW078,4,W0236,09:30,"Setting realistic goals and outcomes for a cohort of patients discharged from a C. auris metagenomics integrationClaire Bertelli (Lausanne, endemic areaM. Bavastro* (Genoa, Italy), L. Switzerland) Mezzogori, M. Bonaffini, L. Magnasco, F. Co-organised with: Danish Society for Clinical Microbiology, ESCMID Study Centorrino, V. Di Pilato, E. Willison, F. Portunato, Group for Genomic and Molecular Diagnostics (ESGMD), Trainee Association D.R. Giacobbe, A. Vena, A. Marchese, M. Mikulska, of ESCMID (TAE) Steering Committee M. Bassetti"
SY082,6,S0243,11:00,"The rise of anti-science: lessons for the future ePoster Flash Session scientistMarion Koopmans (Rotterdam, Netherlands)"
SY082,6,S0244,11:30,"Open science for public trustLisa Hansen (Ottawa, Expanding MALDI-TOF applications Canada) Chair Belen Rodriguez-Sanchez (Madrid, Spain)"
SY082,6,F0259,11:00,"View from medical microbiologyMaeve Doyle machine learningT. Pichl* (Munich, Germany), L. (Waterford, Ireland) Miranda, N. Wantia, K. Borgwardt, J. Sattler"
SY082,6,F0260,11:10,"view from infectious diseasesEoghan De Barra E0365 Rapid antifungal resistance prediction based on (Dublin, Ireland) MALDI TOF mass spectrometryD. Duroux* (Zurich,"
SY082,6,F0261,11:20,"view from trainees (TAE)Christian Kraef Switzerland), Y. Yang, J. Sattler, A. Egli (Copenhagen, Denmark) E0366 Rapid prediction of fluconazole resistance by"
SY082,6,F0262,11:30,"European exam - how to prepare?Annelies Verbon machine-learning analysis of Candida parapsilosis (Bosch En Duin, Netherlands) MALDI-TOF mass profilesC. Magri* (Rome, Italy), C. Magrì, V. Ivagnes, M. Sanguinetti, E. De Carolis"
SY082,6,S0247,11:00,"Human African Trypanosomiasis: recent diagnostic Muñoz, M. Marín, L. Alcalá, D. Rodriguez-Temporal, and medical practicesJean-Mathieu Bart (Conakry, B. Rodriguez-Sanchez Guinea)"
SY082,6,S0248,11:30,"American Trypanosomiasis: Diagnosis, screening and shotgun proteomicsL. Meekes* (Rotterdam, managementTba Netherlands), D. Rustad, C. Güzel, T.K. Jenssen, H. Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) Hauge, C. Klaassen, M. Bexkens, N. Strepis, T. Luider, W. Goessens"
KN081,1,S0253,11:00,"Bacterial PROTACs: Do proteolysis-targeting Caroccia, M. Di Chiara, P. Viale, M. Giannella degraders represent a viable strategy for new antimicrobials?Morreale Francesca Ester (London,"
KN081,1,S0254,11:30,"Activity-based protein profiling of bacterial (Edmonton, Canada), D. You, J. Gratrix, A. Singh, K. pathogens: new enzymes and their functions at the Doucette host-microbe interfaceChristian Stephan Lentz (Tromsø, Norway)"
KN081,1,M0255,11:00,"Gisela Robles Aguilar (Oxford, United Kingdom)"
KN081,1,M0256,11:12,"Mike Sharland (London, United Kingdom)"
OS043,3,S0249,11:00,Role of reflex testing strategies in identifying patients
OS043,3,S0250,11:30,"Management and elimination of hepatitis in hard-to- (Porto, Portugal), A. Gonçalves Rodrigues, L. reach personsSuda Tekin (Istanbul, Türkiye) Cobrado Co-organised with: ESCMID Study Group for Viral Hepatitis (ESGVH), O0325 Sink-associated outbreak of verona integron- Romanian Society for Infectious Diseases and HIV/AIDS encoded metallo-??-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa in a Dutch intensive care unitM. Van Den Bos Kromhout*"
OS043,3,S0251,11:00,"Viability markers in support of development of O0327 Tolerance of Klebsiella pneumoniae biofilms to Chlamydia screening recommendationsPetra Wolffs disinfection with peracetic acidM. Arvand* (Berlin, (Maastricht, Netherlands) Germany), A.M. Richter, D. Csertö, K. Konrat"
OS043,3,S0252,11:30,"Measuring viability to improve the correlation of AMR O0328 Bringing balance to the formulation: disinfection markers and clinical outcomes in Neisseria efficacy and material compatibilityJ. Jennings* gonorrhoeaeTatum Mortimer (Athens, United States) (Halifax, United Kingdom), T. Langford, H. Mansbridge, E. Fraser, I. Poles, J. Clarke Co-organised with: ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)"
ME089,15,M0257,11:00,"Katrien Lagrou (Leuven, Belgium) falciparum isolates from Uganda: results of ERASE studyM. L'episcopia* (Rome, Italy), F.V. Segala, J."
ME089,15,M0258,11:12,"Mihai Mares (Iasi, Romania) Ictho, R. Papagni, I. Obua, E. De Vita, N. Olang, R. Co-organised with: European Confederation of Medical Mycology (ECMM) Novara, V. Totaro, L. Olal, G. Patti, C. Bignom, C. Agaro, G. Dall'oglio, B. Ngole, S. Okori, P. Lochoro, G."
SY083,7,S0245,11:00,"Challenges in diagnosis of Lyme neuroborreliosisRick Sørensen Dersch (Freiburg, Germany)"
SY083,7,S0246,11:30,"Challenges in treatment of Lyme receptor-binding and N-terminal domain COVID-19 neuroborreliosisAnne Marit Solheim (Kristiansand, vaccine versus mRNA-1273: subgroup analysesC. Norway) Grassi* (Cambridge, United States), S. Chalkias, P. Co-organised with: ESCMID Study Group for Infectious Diseases of the Brain Dennis, D. Petersen, K. Radhakrishnan, L. Vaughan, R. (ESGIB), ESCMID Study Group for Lyme Borreliosis (ESGBOR) Handforth, N. Vicic, A. Rossi, R. Wahid, D. Edwards, J. Feng, W. Deng, H. Zhou, E. De Windt, V. Urdaneta, B. Girard, S. Faust, S. Walsh, C. Cosgrove, R. Das"
SY093,11,S0267,13:30,"How immunosenescence impacts vaccine Miami, Florida.A. Jimenez* (Miami, United States), responseAndrea Cossarizza (Modena, Italy) S. Hawken, S. Arenas, K. Mokoban, D. Pronty, O."
SY093,11,S0268,14:00,"Strategies to tackle immunosenescence and improve Martinez, J. Colson, A. Richardson, T. Ferreira, B. immune response to vaccination in the elderlyInna Shukla Ovsyannikova (Rochester, United States)"
SY093,11,W0273,13:30,Developing your educator professional identityTodd
SY093,11,W0274,13:50,"What do IPC doctors need to learn to be Anantharajah* (Brussels, Belgium), C. Altintas, T. preparedSimone Scheithauer (Göttingen, Germany) Lavalleye, A. Delaunoy, I. Meyts, E. Dumitreasa, A."
SY093,11,W0275,14:10,"Communities of practice: successful experience of a Bennert, C. Schirvel, A. Verroken, H. Rodriguez- transformative collaboration and roadmapErin Villalobos Bonura (Portland, United States) E0396 Reversing and controlling microbial proliferation in"
SY093,11,W0276,14:30,"The critical need for ongoing innovations in medical the water system of a high-risk hospital ward after educationClémentine Schilte (Paris, France) extended closure and reconstructionD. Chaput* (Glasgow, United Kingdom), K. Clarkson, L. Co-organised with: Infectious Diseases Society of America (IDSA), ESCMID Bagrade, A. Marek, D. Kelly, D. Watson, A. Leanord, Professional Affairs Subcommittee, Trainee Association of ESCMID (TAE) T. Steele Steering Committee, British Infection Association (BIA), Young Leader Circle of the American Society of Microbiology E0397 Whole-genome sequencing as part of the tracking and managing Carbapenemase producing Enterobacterales transmission in an acute hospital"
SY093,11,F0277,13:30,"Training skilled personnel in LMIC and brain drain: is wastewaterH.A. Craddock* (Dublin, Ireland), A. the solution the problem?Sipho Kenneth Dlamini Kearney, F. Fitzpatrick, C. Finn, M.T. Pryce, D. (Observatory, South Africa) Fitzgerald-Hughes"
SY093,11,F0278,13:40,"Leveraging surveillance networks to strengthen basic bacteriologyDissou Affolabi (Cotonou, Benin)"
SY093,11,F0279,13:50,"Clinical bacteriology laboratories in low-resource EF055 - Arena 4 13:30 14:30 settings: considerations for sustainabilityMakeda Semret (Montreal, Canada) ePoster Flash Session Co-organised with: ESCMID Professional Affairs Subcommittee, Dutch The cutting edge in tuberculosis Society for Medical Microbiology (NVMM), ESCMID Parity Commission,Federation of European Microbiological Societies (FEMS), Chair Graeme Ayton Meintjes (Observatory, South Africa) ESCMID Study Group for Antimicrobial stewardship (ESGAP), Société belge d'Infectiolo"
SY093,11,S0269,13:30,"Foodborne risk in meat and fishery products and impact on AMRAnders Dalsgaard (Frederiksberg C, Selective Pressure Denmark) Chairs Jacob Moran-Gilad (Beer Sheva, Israel) S0270 14:00 Control challenges associated with food-borne Joshua Nosanchuk (Bronx, United States) multidrug resistanceLuisa Maria Vieira Peixe (Porto, Jose Ramon Pano-Pardo (Zaragoza, Spain) Portugal) Jesús Rodríguez-Baño (Seville, Spain) Co-organised with: ESCMID Food- and Water-borne Infections Study Group Anja Šterbenc (Ljubljana, Slovenia) (EFWISG) Suzanne Van Asten (Nijmegen, Netherlands) David Van Duin (Chapel Hill, Nc, United States)"
SY093,11,M0271,13:30,"Karolina Akinosoglou (Patra, Greece)"
SY093,11,M0272,13:42,"Pierre Tattevin (Rennes, France) Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG),"
SY093,11,S0265,13:30,"Sex impacts incidence, management, and outcome in Producing Enterobacterales Using Disk-DiffusionL.K. bacteraemiaAnnette Westgeest (Leiden, Muhsal* (Oldenburg, Germany), C. Cimen, J. Sattler, Netherlands) O. Nolte, L. Dortet, R. Bonnin, A. Egli, A. Hamprecht"
SY093,11,S0266,14:00,The complex interplay between gender and
ME101,14,M0285,14:45,"Esther Calbo (Terrassa, Spain)"
ME101,14,M0286,14:57,"Jan A.J.W. Kluytmans (Utrecht, Netherlands)"
FO102,,F0287,14:45,"Status of the One Health Joint Plan of Action by the Pathways and Immune Evasion in Acinetobacter QuadripartiteChadia Wannous (Paris, France) baumanniiH. Wang* (Beijing, China), C. Jiang"
FO102,,F0288,14:55,National surveillance responsibilities under the
FO102,,F0289,15:05,"Long-term consequences of emerging viral Molina Panadero, A. Lora González, A. Hmadcha diseasesAlfonso J. Rodriguez-Morales (Pereira, Colombia)"
SY091,4,S0263,13:30,"Lessons learnt from previous outbreaksTba Q. Wang, N. Jeoffreys, S. Chen, K. Basile, T."
SY091,4,S0264,14:00,"Disease X: preparedness for the next pandemicYee Golubchik, J. Kok, V. Sintchenko Sin Leo (Singapore, Singapore)"
EF060,,S0283,14:45,"Infant gut microbiome developmentDebby Bogaert Batirel, Y. Onlen, E. Parlak, B. Kurtaran, S. Tosun, I. (Edinburgh, United Kingdom) Yilmaz Nakir, O. Gunal, N. Eser, H. Yaqoobi, O. Tabki, T. Turunc, U. Balci, S. Komur, E.E. Tutuncu, L.N."
EF060,,S0284,15:15,"Metagenomic signatures and antibiotic disruption of Altunal, N.D. Sari, D.S. Yildiz, H.D. Ozkaya, I.E. Yildiz, the gut microbiome in neonatesGautam Dantas (Saint S. Kaya, O. Karabay, S. Alkan, F. Tabak Louis, United States) Co-organised with: ESCMID Study Group for Nosocomial Infections (ESGNI), European Society of Paedriatic Infectious Diseases (ESPID) OS057 - Hall 3 14:45 15:45 1-hour Oral Session"
OS056,2,S0281,14:45,The EUCAST system in surveillance of AMRSören G.
OS056,2,S0282,15:15,"Insights into developments in the surveillance of Hockicková, J. Hockicko, D. Javorská, Š. Zamba, A. HAIsDiamantis Plachouras (Solna, Sweden) Vasiľová, M. Ševčík, A. Cehelská, D. Hudáčková, P. Co-organised with: EUCAST Steering Committee, EUCIC Steering Kristian Committee, European Centre for Disease Prevention and Control (ECDC)"
OS056,2,S0297,16:15,"Communicating to policy makers and for societal antimicrobials with antibiofilm activity against impactBalázs Babarczy (Budapest, Hungary) Staphylococcus aureusA. Nunes* (Lisbon, Portugal),"
OS056,2,S0298,16:45,"Influencing behaviour through the media and a B. Alves, J.P. Carrilho, N.R. Candeias multichannel communications strategyCharlotte Hutchinson (London, United Kingdom)"
EW109,2,W0301,16:15,"Tailoring pharmacologic prophylaxis in patients with Solleder, G. Meleleo, T. Malik, K. Bakker, R. Oidtman non-haematologic cancer: from viruses to fungiJanne Vehreschild (Frankfurt, Germany) E0481 Modeling the public health impact of a 21-valent PCV in the Canadian adult populationO. Sharomi*"
EW109,2,W0302,16:35,"Pneumonitis or pneumonia? A practical approach to (Rahway, United States), R. Oidtman, M.C. Meilleur, lung infiltrates in patients with solid tumoursTba S. Weinrich, K. Bakker"
EW109,2,W0303,16:55,The diagnostic dilemmas and treatment challenges of
EW109,2,W0304,17:15,"HTLV-1 and T-cell lymphoma - predict & preventLucy NorwayZ. Yi* (Rahway, United States), A.A. Tajik, S.T. Cook (London, United Kingdom) Klitkou, E. Tsoumani, K. Owusu-Edusei Co-organised with: ESCMID Study Group for Respiratory Viruses (ESGREV), E0483 Shifting from risk-based to age-based approach for International Immunocompromised Host Society (ICHS) pneumococcal vaccination in adults in France: a comprehensive evaluationO. Sharomi* (Mt Carmel, United States), S. Oluwaseun, M. Breau-Brunel, F."
EF067,,M0299,16:15,"Sophie Schneitler (Homburg, Germany)"
EF067,,M0300,16:27,"Andreas Neumayr (Basel, Switzerland)"
EF067,,S0295,16:15,"Strain dynamics in serious bacterial infections in infantsDrew Schwartz (Saint Louis, United States)"
EF067,,S0296,16:45,"Long-term colonisation dynamics of carbapenemase- 16:15 18:15 producing EnterobacteralesNiranjan Nagarajan 2-hour Oral Session (Singapore, Singapore) Heterogeneity and complexity of sepsis Chairs Despoina Koulenti (London, United Kingdom) OS064 16:15 - 17:15 Hall 16 Sylvain Meylan (Lausanne, Switzerland) 1-hour Oral Session Viral immune response - nature or nurture? Exploring the limits of immune"
OS064,16,S0291,16:15,"Standard prophylaxisMaddalena Giannella (Bologna,"
OS064,16,S0292,16:45,"Targeted approachesMaristela P. Freire (Sao Paulo, García-Giménez, L. Piles, M. Madrazo, G. Judit, M. Brazil) López-Torres, A. Artero Co-organised with: European Association for the study of the liver (EASL)"
OS064,16,L0022,17:27,"Initial vancomycin taper for the prevention of recurrent Clostridioides difficile infection: the TAPER- V randomised controlled trialE.G. Mcdonald* (Montreal, Canada), Y. Chen, B. Coburn, N. Daneman,"
OS064,16,S0293,16:15,"Novel beta-lactams and beta-lactamase inhibitors: S. Hota, C. Frenette, C.E. Kandel, L. Kong, Y. Longtin, challenges for laboratory diagnosticsAnna Sramkova V.G. Loo, D. Macfadden, M. Muller, T.S. Steiner, L. (Pilsen, Czech Republic) Valiquette, T.C. Lee"
OS064,16,S0294,16:45,"Clinical perspectives of novel beta-lactams and beta- L0023 17:39 Beneficial effects of a clinical metagenomics lactamase inhibitorsParikshit Prayag (Pune, India) intervention on clinical outcomes, healthcare Co-organised with: EUCAST Steering Committee economics, and quality of life in patients with sepsis/septic shock: results of the DigiSep-trialT. Brenner* (Essen, Germany), A. Skarabis, S.J."
OS064,16,L0016,16:15,"Temocillin versus meropenem for the targeted Schwerhoff, S. Grumaz, M. Steinmann, M. Gaasch, B. treatment of bacteraemia due to third-generation Pasieka, U. Jaekel, T. Brandenburger, F. Bach, H. cephalosporin-resistant Enterobacterales (ASTARTÉ): Mutlak, S. Utzolino, M.M. Berger a randomised, pragmatic trialF. Cogliati Dezza* (Seville, Spain), L. Barrera Pulido, I. Borreguero L0024 17:51 Shortened antibiotic treatment for 5 days in patients Borreguero, F. Docobo Peréz, V. Palomo Jiménez, S. hospitalised with community-acquired pneumonia De La Rosa Riestra, J. Bravo-Ferrer Acosta, M.A. (CAP5): a multicentre randomised controlled Lopez Zuñiga, F. Cobo, J. Gómez-Junyent, J.P. noninferiority trialS. Bastrup Israelsen* (Hvidovre, Horcajada, E. Merino, M. Parra, J. Lopéz-Contreras, Denmark), L. Hagens Mygind, F. Al-Zergani, B. A. Rivera, D. Sousa Regueiro, M. Pampin Garcia, S. Lindegaard, A. Knudsen, S. Tingsgård, L. Thorlacius- Lopez Cardenas, M.C. Goméz Sanchez, I. Peréz Ussing, I. S Johansen, H. Nielsen, P. Ravn, T. Benfield Camacho, S.M. Martin Ramos, E. Leon Jimenez, A.I. L0025 18:03 High-dose rifampicin in the treatment of tuberculous Aller García, M.T. Peréz-Rodríguez, A. Sousa, M.C. meningitis: results of the HARVEST phase III multi- Fariñas, A.D.L.R.A. Fracisco, L. Gisbert Pérez, J. country randomised clinical trialR. Van Crevel* Goikoetxea Agirre, A. Cano, F.J. Martínez-Marcos, (Nijmegen, Netherlands), D. Meya, R. Rovina, D. M.J. García País, R. Escudero Sanchez, S. De La Villa, Boulware, B. Dai, N. Engen, F. Cresswell, K. Naidoo, A. J.R. Yuste Ara, M.A. Esteban-Moreno, A. Ruiz- Rizal, D. Imran, R. Lessels, L. Tugume, R. Hamers, M. Sancho, M. Pedrosa Aragón, J. Alba Fernandez, A. Kabahubya, S. Marais, Y. Moosa, N. Bahr, E. Barrios Blandino, H.H. Vilchez Rueda, R. Álvarez- Svensson, L. Te Brake, R. Aarnoutse Marín, A. Romero Palacios, A.E. Roura Piloto, E. Nuño Álvarez, Z.R. Palacios Baena, L. López Cerero, J. Rodríguez-Baño EF074 - Arena 1 17:30 18:30"
OS064,16,L0017,16:27,"HRS-8427 versus imipenem-cilastatin for complicated urinary tract infections: a randomised, ePoster Flash Session double-blind phase 2 studyM. Ju* (Shanghai, China), M. Wang, J. Yuan, H. Huang, G. Bi, J. Lyv, X. Lyv, L. New methods for rapid pathogen detection and typing Xue, H. Yang, D. Fan, H. Wu, X. Wang, J. Xu, X. Li, Q. Chair Sylvain Brisse (Paris, France) Zhang"
OS064,16,L0018,16:39,Efficacy and safety in a Phase 2 study of intravenous
OS064,16,L0019,16:51,"Neutralising plasma versus placebo for hospitalised patients with West Nile fever: a double-blind E0534 Strategy for the rapid typing of Salmonella spp using randomised controlled trialM. Canetti* (Tel Aviv, infrared spectroscopy: a one health perspectiveJ. Israel), G. Regev-Yochay, N. Barda, Y. Shusterman, E. Jiménez* (Santiago, Chile), D. Fredes, A. Piña, I. Magiel, N. Baharav, A. Belkin, I. Margalit, V. Mercado, J. Miranda, S. Henríquez, T. González, A. Indenbaum, E. Tomer, Y. Lustig, Y. Ottolenghi, G. Adell, A. Moreno-Switt, A. Wozniak, P. García Joseph, H. Yonath, E. Leshem, I. Levy, Y. Peretz, S. E0535 WGS-based surveillance as a paradigm shift in Amit, L. Miller, M. Misgav, N. Landa, M. Brod, A. outbreak detection, AMR monitoring and source Wieder-Finesod, N. Maggio, D. Yahav attribution in CampylobacterA. Nunes* (Lisbon,"
OS064,16,L0020,17:03,"Randomised placebo controlled trial of faecal Portugal), M.L. Lemos, S. Ortiz, I. Santos, S. Ramos, microbiota transplantation to tackle antimicrobial M. Oleastro resistance: inducing bacteriophage network E0536 Prevalence of Staphylococcus aureus clonal complex remodelling and enteric pathogen reductionL.A. 97 amongst BORSA isolates in a large UK hospitalH. Edwards* (London, United Kingdom), B. Auch, T. Gareth* (Birmingham, United Kingdom) Portlock, B.H. Mullish, B. Merrick, C. Woodhouse, T."
OS064,16,L0021,17:15,Double-dose dolutegravir and lamivudine versus Huang efavirenz-based antiretroviral therapy for patients
EF076,,S0309,17:30,"Li Yang Hsu (Singapore, Singapore) Detecting E. histolytica cfDNAP. Datta* (Chandigarh,"
EF076,,S0310,18:00,"Rita Oladele (Lagos, Nigeria) India), D. Rattan, A. Duseja, N. Sharma, N. Kalra, S. Khurana"
SY111,11,S0307,17:30,"PK/PD from the EUCAST/regulatory perspective: Bocanegra, M. Gonzálvez, A. Beato-Benítez, R. what tools do we need?Joseph Meletiadis (Athens, Cuadrado-Matías, M.Á. Quevedo, R. Guerra, R. Greece) Martínez, A. Rivero-Juárez, J. Martínez, E. Martínez-"
SY111,11,S0308,18:00,"PK/PD for new anti-TB drugs Elin Svensson (Uppsala, Nevado, P. Soriano, D. Crailsheim, J. Lazpita, A. Sweden) González, P. Foronda, J. Caballero-Gómez Co-organised with: ESCMID PK/PD of Anti-Infectives Study Group (EPASG)"
SY111,11,S0306,18:00,"Dysregulated host responses to infectionMichal Mageau, T. Mirault, A. Pellat, C.A. Hobson, D. Bouzid, Holub (Praha, Czech Republic) M. Thy, N. Peiffer-Smadja"
SY111,11,S0323,08:30,"Vector-borne diseases in Europe and clinical Temporiti, N. Pujato, S. Claudia, D. Calfunao, C. consequencesTuba Dal (Ankara, Türkiye) Nyveyro, M. Martinez, A. Smud, P. Giorgio, L. Barcán"
SY111,11,S0324,09:00,Rising temperatures and risks of fungal
SY111,11,S0325,09:30,"Strategies for climate prevention and adaptation in a R. Ville-Benavides, I. Avendaño-Gutiérrez moving worldKristie Ebi (Seattle, United States)"
SY111,11,S0326,10:00,"AMR in climate change-affected countriesEsmita with cidofovir in a renal transplant recipientA. Kaya* Charani (London, South Africa) (Izmir, Türkiye), G.S. İzgi, B. Yaman, Y. Tiftikçioğlu, I. Karaaslan, M. Taşbakan Co-organised with: ESCMID Study Group for Infections in Travellers and Migrants (ESGITM)"
SY111,11,S0305,17:30,IRIS in HIV immunocompromised hosts: a failure of E0578 Battlefield Stewardship: Implementing Antimicrobial Management in the Ukrainian Trauma PathwayH.
SY111,11,W0335,08:30,"Laboratory identification of AmpC and its impact on Benedetto, N. Ramponi, M. Mombelli, N. Centemero, /i>in vitro resistanceAna Gales (Sao Paulo, Brazil) A. Colombo, D. Destefani, M. Bissig, E. Bernasconi W0336 08:50 Divergent levels of AmpC expression in Gram-"
SY111,11,W0337,09:10,"Rational choice of antimicrobial therapy against stewardship in a Ugandan tertiary care hospitalL. AmpC-producing pathogensPatrick Harris (Herston, Jung* (Leipzig, Germany), L. Atikoro, D. Owachi, A. Australia) Schneider, S. Schönherr, A. Von Braun, C. Kabugo"
SY111,11,W0338,09:30,"Novel antimicrobials active against AmpC: what RCTs tell us in support of their use?Amy Mathers (Charlottesville, United States)"
SY111,11,S0315,08:30,"The ESCMID-ISF Sepsis Award LectureAndrew Acinetobacter baumannii ST2: Insights from the Moore (Emerald Hills, United States) BALANCE studyC. Abdellaoui* (Oxford, United"
SY111,11,S0316,08:45,"The WHO Global Maternal Sepsis StudyCarolina Kingdom), R. Farzana, M.N. Haque, M. Sultana, A. Carvalho Ribeiro Do Valle (Sao Paulo, Brazil) Sharmin, R.I. Rony, T. Ahmed Rifat, Z.T. Chaity, S. Afroj, S. Parvin, M. Ea De Kraker, S. Harbarth, N. S0317 09:15 Sepsis: year in reviewSylvain Meylan (Lausanne, Hassoun-Kheir, M. Hamza, G. Jana, S. Jamshaid, R. Switzerland) Yaseen, G. Fatima, M. Nawaz, S.N.Z. Rizvi, U. S0318 09:45 How to design and implement a Sepsis National Ibrahim, K. Shafique, A. Naqvi, R. Zahra, B. Hassan, Action Plan (SNAP)Erika Vlieghe (Edegem, Belgium) E. Carretto, K. Sands, K.J. Hoog, T.R. Walsh Co-organised with: ESCMID Study Group for Bloodstream Infections,"
SY111,11,S0313,09:30,"Crimean Congo Haemorrhagic Fever: Newer insights Chairs Gaetan Gavazzi (Grenoble, France) into pathogenesis leading to new vaccines and Giusy Tiseo (Pisa, Italy) therapeuticsAli Mirazimi (Stockholm, Sweden)"
SY111,11,S0314,10:00,"Venezuelan Equine Encephalitis: Impact of newer strategies for vector controlCarlos Seas (Lima, Peru)"
SY111,11,S0319,08:30,"The burden of nosocomial infections in long-term facilities Virginie Prendki (Genève-Thônex, OS078 - Hall 5 Switzerland) 08:30 10:30"
SY111,11,S0320,09:00,"Pneumonia in the elderly: management and 2-hour Oral Session preventionMarcos Restrepo (San Antonio, United States) Trending topics in tuberculosis"
SY111,11,S0321,09:30,"Challenges in the clinical diagnosis of infection in the Chairs Delia Goletti (Rome, Italy) elderlyMaheen Abidi (Denver, United States) Sean Wasserman (London, United Kingdom)"
SY111,11,S0322,10:00,"Challenges in implementing antimicrobial stewardship in long-term care facilitiesElena Carrara (Verona, Italy) O0568 Lineage-specific immune responses to Co-organised with: ESCMID Study Group for Infections in the Elderly (ESGIE), Mycobacterium tuberculosis: insights into L4 and ESCMID Study Group for Nosocomial Infections (ESGNI), EUCIC Steering L6 pathogenesisM. Silva* (Porto, Portugal), J. Committee Couto, M. Cardoso, B. Cá, M. Saraiva"
SY117,16,S0327,08:30,"Nitroimidazole refractory Giardia intestinalis Wasserman, G. Meintjes, A. O' Garra infectionPavla Tůmová (Praha, Czech Republic)"
SY117,16,S0328,09:00,"Treatment failure in scabiesFrancisco Bravo (Lima, Mycobacterium tuberculosis can give rise to Peru) rifampicin resistance and shed light on how"
SY117,16,S0329,09:30,"Recurrent Enterobius infectionsSarah Eisen (London, resistance is acquiredV. Brunner* (Oxford, United United Kingdom) Kingdom), P. Fowler"
SY117,16,S0330,10:00,"Recent advances in the treatment of Visceral O0572 A systematic comparison of automated Leishmaniasis and PKDLShyam Sundar (Varanasi, Mycobacterium tuberculosis complex whole India) genome sequencing analysis pipelinesR. Spies* (Ho Co-organised with: ESCMID Study Group for Clinical Parasitology (ESGCP) Chi Minh City, Vietnam), D. Crook, T. Peto, P. Fowler, R. Turner, H. Thai, J. Watson, T. Walker"
SY117,16,W0331,08:30,"Evolutionary modelling of plasmidsManuel Ares Arroyo (Paris, France) O0575 Rapid drug susceptibility testing of Mycobacterium tuberculosis directly from clinical samples using"
SY117,16,W0332,08:50,"How plasmids shape the emergence of nosocomial targeted next-generation sequencingE. Rosendal* pathogensJukka Corander (Oslo, Norway) (Lisbon, Portugal), J. Isidro, S. Carneiro, R. Macedo"
SY117,16,W0333,09:10,Understanding the complexity of plasmid outbreaks
SY117,16,W0334,09:30,"Plasmid transmission at the One Health pharmacodynamic studiesK. Jadhav* (Sas Nagar, interfaceNicole Stoesser (Oxford, United Kingdom) India), K. Sudhakar Jadhav, A.K. Singh, R.K. Verma Co-organised with: ESCMID Study Group for Epidemiological Markers O0577 Multi-drug resistant tuberculosis among migrants (ESGEM), ESCMID Study Group for Veterinary Microbiology (ESGVM) in EuropeS. Hayward* (London, United Kingdom), K. Rustage, L.B. Nellums, J.S. Friedland, S. Hargreaves"
SY117,16,S0311,08:30,"Filovirus disease: evolving therapeutic strategiesIan Crozier (Frederick, United States)"
SY117,16,S0312,09:00,"Jack in the box: Re-emergence of Kyasanur Forest S0339 09:30 Mario Ramirez (Lisbon, Portugal) Disease in IndiaKavitha Saravu (Manipal, India) S0340 10:00 Anna Papa-Konidari (Thessaloniki, Greece)"
EF081,,F0356,11:00,"The genesis of predatory journals: symptoms and root problemsLeonard Leibovici (Petah-Tiqva, Israel)"
EF081,,F0357,11:10,"The role of editors and publishers of ‘reputable multicentre study in 46 hospitals from Australia and journals’: what can they do to stop predatory New ZealandJ. Coussement* (Melbourne, Australia), journals?Till Bärnighausen (Heidelberg, Germany) C.H. Heath, M.B. Roberts, R.J. Lane, T. Spelman, O.C. F0358 11:20 The roles of authors and academic institutions: Smibert, A. Longhitano, C.O. Morrissey, B. Nield, M. towards governance and regulation Luigia Scudeller Tripathy, J.S. Davis, K.J. Kennedy, S.A. Lynar, L.C. (Pavia, Italy) Crawford, S.J. Crawford, B.J. Smith, A.P. Gador-"
EF081,,F0359,11:30,"Bibliometric literacy in scientific publicationLauren Whyte, R. Haywood, A.A. Mahony, J.C. Howard, G.B. Maggio (Chicago, United States) Walls, G.M. O’kane, M.T. Broom, C.L. Keighley, O. Bupha-Intr, L. Cooley, J.A. O’hern, J.D. Jackson, A.J. Co-organised with: CMI Communications Board of Editors Morris, C. Bartolo, A.R. Tramontana, K.C. Grimwade, V. Au Yeung, R. Chean, E. Woolnough, B.W. Teh, M.A. Slavin, S.C.A. Chen EF089 - Arena 2 11:00 12:00"
OS085,10,S0350,11:00,"The concept of complicated UTI: underlying Blanchard, O. Lortholary conditions matterSuzanne Geerlings (Amsterdam,"
OS085,10,S0351,11:30,"The concept of complicated UTI: the site of infection following allogeneic hematopoietic stem cell matters mostJesús Rodríguez-Baño (Seville, Spain) transplantation: a prospective cohort studyS. Co-organised with: ESCMID Education Subcommittee Haggenburg* (Amsterdam, Netherlands), J. Schnyder, H. Garcia Garrido, M. Schoordijk, A. Reiners, B. Meek, M. Hazenberg, A. Goorhuis"
OS085,10,M0354,11:00,"Jennifer Rohn (London, United Kingdom) OS082 - Hall 2 11:00 12:00"
OS085,10,M0355,11:12,"Nathalie Sauvonnet (Paris, France) 1-hour Oral Session New insights in bloodstream infections and endocarditis"
OS085,10,S0342,11:00,"The lung microbiome of people with cystic fibrosis receiving modulator therapySebastien Boutin SY125 - Hall 7 (Lübeck, Germany) 11:00 12:00"
OS085,10,S0343,11:30,"Tackling chronic infections in people with cystic 1-hour Symposium fibrosis receiving modulator therapy: is it still necessary?Alessandra Bragonzi (Milano, Italy) Cutting edge methods in mycology Co-organised with: ESCMID Study Group for Biofilms (ESGB), Czech Society Chairs Katrien Lagrou (Leuven, Belgium) for Medical Microbiology Antonio Vena (Genova, Italy) SY123 11:00 - 12:00 Hall 4"
SY123,4,S0348,11:00,"Imaging for diagnosing mycoses: focus on 18F-FDG PET/CTAna Fernández-Cruz (Majadahonda (Madrid), 1-hour Symposium Spain) Infection prevention and control and intensive care: challenges and solutions S0349 11:30 Exploring the intersection of fungal metagenomics and medical mycologyMarcus De Melo Teixeira Chairs Antonios Katsounas (Bochum, Germany) (Brasília, Brazil) Claire Roger (Nimes, France) Co-organised with: ESCMID Fungal Infection Study Group (EFISG), ESCMID Education Subcommittee, Medical Mycology Study Group (GEMICOMED) within the SEIMC (Spanish Society of Infectious Diseases and Clinical"
SY123,4,S0344,11:00,"Intensive care unit (ICU) and infection: two sides of a Microbiology), ESCMID Study Group for Critically Ill Patients (ESGCIP), coinReto Schuepbach (Zurich, Switzerland) Società Italiana per la Terapia Antinfett"
SY123,4,S0345,11:20,"Ventilator- associated pneumonia (VAP) and ICU enviroment: how can we improve practices?Despoina Koulenti (London, United Kingdom) OS084 - Hall 8 11:00 12:00 Co-organised with: ESCMID Study Group for Critically Ill Patients (ESGCIP), 1-hour Case Session EUCIC Steering Committee Weird and unusual infections"
SY123,4,M0352,11:00,"Erika Matuschek (Växjö, Sweden)"
SY123,4,M0353,11:12,"Rafael Canton (Madrid, Spain) Co-organised with: EUCAST Steering Committee"
SY123,4,S0346,11:00,"Why treat IV when PO is possible?Bradley Spellberg (Los Angeles, United States)"
SY123,4,S0347,11:30,"De-escalation of antibiotic therapy to narrow- ME134 - Hall 16 13:30 14:30 spectrum IV drugsFlaminia Olearo (Hamburg, Germany) Meet-the-Expert Co-organised with: CMI Communications Board of Editors, ESCMID AMR The older solid organ transplant recipient: between frailty, Action Subcommittee, ESCMID Study Group for Antimicrobial stewardship immunosenescence and infection (ESGAP), Trainee Association of ESCMID (TAE) Steering Committee, ESCMID Scientific Affairs Subcommittee"
SY123,4,M0367,13:30,"Maheen Abidi (Denver, United States)"
SY123,4,M0368,13:42,"Alaa Atamna (Petah-Tikva, Israel) senescence biomarkers during injectable Co-organised with: ESCMID Study Group for Infections in Compromised cabotegravir/rilpivirine treatmentM. Mazzitelli* Hosts (ESGICH), ESCMID Study Group for Infections in the Elderly (ESGIE) (Padua, Italy), M.R. Petrara, C. Cozzolino, L. Sasset, D. Leoni, S. Gardin, E. Ruffoni, A. De Rossi, A. Cattelan"
SY131,2,S0361,13:30,"The impact of current and future vaccines on AMR: Martínez-Sanz, M.D. Corbacho, M. Suárez, C. Cano, from pneumococcal to COVID-19Mateusz Hasso- R. Ron, M.J. Cárdenas-Isasi, M. Vélez-Díaz-Pallarés, Agopsowicz (Geneva, Switzerland) S. Moreno, M.J. Pérez-Elías"
SY131,2,S0362,14:00,Can vaccines against AMR be translated into
EW135,3,W0369,13:30,"Designing high-quality research studies: Martín, M. Montero-Alonso, J.L. López-Hontangas methodological skills and knowledgeMical Paul E0675 Effect after Switching from Efavirenz to Rilpivirine on (Haifa, Israel) Liver Steatosis Among People Living with HIV with"
EW135,3,W0370,13:50,"How to design and run scientific studies using AI Non-Alcoholic Fatty Liver Disease: A Randomized agents as research assistantsAlyssa Bilinski Controlled TrialL. Srikham* (Sakon Nakhon, (Cambridge, United States) Thailand), S. Sriphoosanaphan, O. Putcharoen"
EW135,3,W0371,14:10,"Designing your first study: how to construct a E0676 Impact of maternal dolutegravir on growth outcomes workable project when your work environment may of HIV-exposed uninfected children: A prospective not helpThomas Tängdén (Uppsala, Sweden) studyE. Yoram* (Morongoro, Tanzania, United republic of), E. Luoga, S. Glanzman, F. Vanobberghen,"
EW135,3,W0372,14:30,"Bridging early-career professionals with partners and M. Weisser, E. Dotto, G.J. Mollel, G. Sigalla, E. seniorsGiorgia Caruana (Sion, Switzerland) Nyenza, L. Moshi, L. Wilson, J. Okuma, D. Paris Co-organised with: CMI Board of Editors, CMI Communications Board of Editors, Trainee Association of ESCMID (TAE) Steering Committee"
EW135,3,F0373,13:30,"How to avoid parity traps in ID/CM research?Muge dengue surveillance in Catalonia (Northeastern Cevik (St Andrews, United Kingdom) Spain)L. Horvath* (Barcelona, Spain), L. Horvath"
EW135,3,F0374,13:40,"Gender gaps in visibility at scientific Ruiz, J. Navero, M. Navarro, M. Pujada, A. Navarro, conferencesSarah Delliere (Paris, France) M. Garrido, B. Herrerías, P. Rodríguez, N. Zancada, B. Escudero-Perez, M.J. Martinez"
EW135,3,F0375,13:50,"Psychological determinants of empowerment at individual and societal levelTba E0678 Sequence-Independent Single-Primer Amplification (SISPA) followed by Next-Generation Sequencing Co-organised with: ESCMID Education Subcommittee, ESCMID Parity for Diagnosing Viral Respiratory Tract InfectionsP. Commission Trindade* (Santa Maria, Brazil), B.C. Casarin, T.R. Y Castro, B.C. Piccoli, V.T. Santos, L.F. Tessele, A.V. Schwarzbold EF093 13:30 - 14:30 Arena 2"
OS092,14,S0365,13:30,"Probiotics in infectious diseases: the perfect complement to antimicrobial therapies?Lena Biehl (Cologne, Germany) PM3 13:30 - 14:30 Hall 12"
OS092,14,S0366,14:00,"The horizon of next generation probiotics for Meet-the-Innovators infectious diseasesCormac Gahan (Cork, Ireland) Future prospects of electronic clinical decision support systems in Co-organised with: ESCMID Study Group for Host and Microbiota Interaction stewardship programs (ESGHAMI)"
OS092,14,S0363,13:30,"Impact of the WHO’s developed catalogue of Aanensen, G. Frankel, K. Beis mutations on rapid TB diagnosis and O0660 Clinical carbapenem-resistant Klebsiella pneumoniae treatmentThomas Schön (Kalmar, Sweden) (CRKP) strains carrying a mutH mutation are"
OS092,14,S0364,14:00,"Antimicrobial resistance prediction using whole hypermutators that have heightened virulence and genome sequencingPatricia Simner (Rochester, readily develop �-lactam/�-lactamase resistanceS. United States) Cheng* (Pittsburgh, United States), C. Clancy, M.H. Nguyen, B. Hao, G. Liu Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS), ESCMID Study Group for Epidemiological Markers O0661 Genomic insights into the new prophages of MDR (ESGEM), EUCAST Steering Committee Pseudomonas aeruginosa: an example of phage- host-phage interactionA. Uskudar Guclu* (Ankara,"
OS098,15,M0381,14:45,"Vítor Borges (Lisbon, Portugal)"
OS098,15,M0382,14:57,"Clare Sloggett (Melbourne, Australia)"
OS098,15,S0379,14:45,Bacterial meningitis diagnosis and surveillanceDivya
OS098,15,M0383,14:45,"Shruti Gohil (Irvine, United States) Deodhar (Muscat, Oman)"
OS098,15,M0384,14:57,"Jose Ramon Pano-Pardo (Zaragoza, Spain)"
OS098,15,S0380,15:05,"Clinical presentation and management of CNS infectionsKartika Maharani (Jakarta, Indonesia)"
OS095,2,S0391,16:15,"Pros and cons of passive infant immunisation with and readmission in community-acquired mAb before their first RSV seasonFederico Martinón- pneumonia.F. Al-Zergani* (Hvidovre, Denmark), C. Torres (Santiago De Compostela, Spain) Lundetoft Clausen, P. Ravn, M. Sebastian Roldgaard, L. Kolte, H. Sarac, M. Fally, S. Bastrup Israelsen, T. S0392 16:45 Pros and cons of maternal vaccination in preventing Benfield severe RSV infections in infants.Anne Vergison (Luxembourg, Luxembourg)"
OS095,2,S0377,14:45,"Carbapenemase-producing Enterobacterales: the not Zannella* (Naples, Italy), F. Passeggio, F. Napolitano, so good, the bad and the ugly.Arjana Tambic A. De Filippis, F. Arcadio, C. Marzano, I. Tavoletta, L. Andrasevic (Zagreb, Croatia) Zeni, M. Galdiero, G. Portella, N. Cennamo"
OS095,2,S0378,15:15,"The P. aeruginosa frightening cocktail: high-risk E0745 Insufficient sexual health bloods don't always need clones, horizontally-acquired resistance and evolving throwing away!S. Hutchings* (Bristol, United mutational resistomeKaty Jeannot (Besançon, Kingdom), R. Hopes, P. North, W. Stoate, M. Murphy, France) G. Beckley, J. Gabb Co-organised with: ESCMID Study Group for Antimicrobial Resistance E0746 A comparison of 4 HAV serology assays: the value of Surveillance (ESGARS) consensus results as a reference standardT. Chin* (Ghent, Belgium), E. Padalko"
EF105,,S0389,16:15,"Vaccination against respiratory pathogensAlbert Schrijvers, I. Spriet, G. Van De Sijpe, L. Gilissen, C. Vollaard (Bilthoven, Netherlands) Breynaert, T. Ieven, P. De Munter"
EF105,,S0390,16:45,"Other vaccinesOlivier Epaulard (Grenoble, France)"
EF105,,W0395,16:15,"How to detect hospital outbreaksDavid Fisman Katz, A. Ceentavida, R. Kozak, C. Vermeiren, P. (Toronto, Canada) Sheldrake, S. John, A. Belhaj, S. Hsieh, S. Patel, R. Lovinsky W0396 16:35 How to confirm hospital outbreaks using genomicsJohn W. A. Rossen (Groningen,"
EF105,,W0397,16:55,"How to rapidly respond to an ongoing hospital Staphylococcus aureus (PRIMEKA): A Retrospective outbreakErmira Tartari (Msida, Malta) Single-Center Cohort Study.F. Salvati* (Rome, Italy), W0398 17:15 How to communicate hospital outbreaks via scientific F. Giovannenze, G.M. Leanza, M. Chiuchiarelli, A. publicationInes Steffens (Solna, Sweden) Frater, M.L. Colombo, F. Iannarelli, B. Fiori, T. D'inzeo, R. Murri, C. Torti"
EF105,,M0393,16:15,"Olivier Lortholary (Paris, France) L0027 First detection of tick-borne encephalitis virus in"
EF105,,M0394,16:27,"Janis Blair (Phoenix, United States) Belgian ticks, May 2024E. Portell-Buj* (Stockholm, Sweden), C. Philippe, S. Van Gucht, F. Dufrasne"
EF105,,S0385,16:15,"Human genomics approaches to infection sequencing dataY. Zhong* (Liverpool, United immunityFergus Hamilton (Bristol, United Kingdom) Kingdom), A. Gerada, A. Howard, P. Green, W. Hope"
EF105,,S0386,16:45,Applying bacterial GWAS to uncover new
EF105,,S0387,17:15,Evolution in action: large-scale within-host evolution analyses of persistent bacterial infectionsStefano
EF105,,S0388,17:45,"Machine learning in bacterial genomics and Foster-Nyarko, L. Urban metagenomicsFrancesco Asnicar (Trento, Italy)"
EF112,,M0403,17:30,"Martina Lengerova (Brno, Czech Republic) Ana Vale (Dublin, Ireland) M0404 17:42 Henrik Hasman (Copenhagen, Denmark)"
EF112,,S0399,17:30,"Threat of highly pathogenic avian influenza to non- OS107 17:30 - 18:30 Hall 3 traditional hosts, including humansThijs Kuiken 1-hour Oral Session (Rotterdam, Netherlands)"
OS107,3,S0400,18:00,"Recent changes in the epidemiology of avian Novel vaccines in clinical development influenza in relation to human health risksRon Chairs Mateusz Hasso-Agopsowicz (Geneva, Switzerland) Fouchier (Rotterdam, Netherlands) Hanna M. Nohynek (Helsinki, Finland) Co-organised with: ESCMID Food- and Water-borne Infections Study Group (EFWISG), ESCMID Study Group for Veterinary Microbiology (ESGVM), ESCMID Study Group for Respiratory Viruses (ESGREV), European Scientific Working group on Influenza (ESWI) O0770 Safety and immunogenicity of a seasonal booster dose of the 6-valent, OspA-based Lyme borreliosis vaccine candidate VLA15 in a healthy population aged"
OS107,3,S0401,17:30,"Expansion and diversity of cystic States), D. Leitner, M. Waldor, L. Baden, M. echinococcosisPedro Legua (Lima, Peru) Desjardins, M. Suzuki, L. Carr, D. Slater, H. Levine, H."
OS107,3,S0402,18:00,"Management of echinococcosis: evidence, eminence Kaul, J.B. Park Chang, A. Piermatti, N. Puri, B. and new developmentsBeate Grüner (Ulm, Germany) Piantadosi, J. Harris, S. Piantadosi, A. Sherman, S. Co-organised with: Österreichische Gesellschaft für Antimikrobielle Walsh Chemotherapie (ÖGACH), Österreichische Gesellschaft für Hygiene, O0773 Safety and immunogenicity of a Group B Mikrobiologie und Präventivmedizin (ÖGHMP), Österreichische Gesellschaft Streptococcus vaccine in participants aged 55-75 für Infektionskrankheiten und Tropenmedizin (OEGIT), ESCMID Study Group yearsL. Oostvogels* (Frederiksberg, Denmark), A. for Infections in Travellers and Migrants (ESGITM) Alhatemi, S. De Gussem, E. Englev, B. Jacobs, B. Johansson-Lindbom, G. Kitson, G. Waerlop, I. Leroux- Roels"
OS107,3,S0417,08:30,"Do we need to redefine the concept of febrile vaccine development programmeL. Tindale* neutropaenia in the era of immunotherapy?Manuela (Toronto, Canada), J. Richardson, D. Anderson, J. Aguilar-Guisado (Seville, Spain) Mendy, S. Muhammad, T. Loreth, V. Jenkins, P. Ajiboye, L. Bedell S0418 09:00 Should some patients be empirically treated with combination therapy?Dina Averbuch (Jerusalem, Israel)"
OS107,3,S0419,09:30,"Role of new antibiotics in febrile 17:30 18:30 neutropaeniaMalgorzata Mikulska (Genoa, Italy) 1-hour Oral Session"
OS107,3,S0420,10:00,"Can treatment strategies be personalised using AI or new diagnostic tools?Carolina Garcia Vidal Novel approaches to preventing device-related infections (Barcelona, Spain) Chairs Natividad Benito (Barcelona, Spain) Co-organised with: ESCMID Study Group for Infections in Compromised Preeti Malani (Ann Arbor, United States) Hosts (ESGICH), European Conference on Infections in Leukemia (ECIL)"
EW156,5,W0429,08:30,"Communicating with journals, editors and O. Moerer, V. Rohde, N. Srivastava, T. Asendorf, K. reviewersAngela Huttner (Geneva, Switzerland) Antweiler, D. Mielke, G. Uwe, N. Lennart, S. Friedrich, A. Beste, N. Kucheryava, M. Baehr W0430 08:50 The Wild West of predatory journalsUrsula Hofer (London, United Kingdom)"
EW156,5,W0431,09:10,"Communicating your publications on social mediaNeil systematic review and meta-analysisA. Mahajan* Stone (London, United Kingdom) (Melbourne, Australia), C. Robson W0432 09:30 Re-imagining peer reviewAmelia Joseph"
EW156,5,S0413,08:30,"Ukrainian war refugees and vaccination attitudes: Immunocompromised Patients: A Dual Approach with experience from PolandMaria Ganczak (Zielona Gora, Modern Molecular Methods: MLST & nested real- Poland) time HRMP. Rani* (Chandigarh, India), P. Datta, S.L."
EW156,5,S0414,09:00,"Vaccination in migrants in Latin America: The Bhasin, P. Malhotra, S.S. Rana, R. Sehgal challenges of transit through Darien, PanamaAlfonso E0825 Prevalence and diagnostic accuracy of different J. Rodriguez-Morales (Pereira, Colombia) diagnostic tests for Chagas disease in the"
EW156,5,S0415,09:30,"Are penitentiary systems ready for introducing Paraguayan ChacoS. Ardiles Ruesjas* vaccination programmes?Lara Tavoschi (Pisa, Italy) (Saarbruecken, Germany), S. Ardiles-Ruesjas, V. Lesmo, V. González-Romero, Z. Cubilla, L. Chena, C."
EW156,5,S0416,10:00,"HPV and other essential vaccinations for sex Huber, M.J. Rivas, P. Saldaña, A. Carrascosa, S. workersDebora Konopnicki (Brussels, Belgium) Méndez, S. Sanz, S.L. Becker, J. Alonso-Padilla, I. Co-organised with: ESCMID Vaccine Study Group (EVASG) Losada"
OS113,11,S0407,09:30,"What are the right bugs – Developing LBPs out of Using mathematical and epidemiological models to identify the drivers of FMTsLena Biehl (Cologne, Germany) AMR"
OS113,11,S0408,10:00,"What’s up next? – Hot LBP candidatesIlan Youngster Chairs Marc J.M. Bonten (Utrecht, Netherlands) (Beer Yaakov, Israel) Sarah Tschudin Sutter (Basel, Switzerland) Co-organised with: ESCMID Study Group for Host and Microbiota Interaction (ESGHAMI), The European Faecal Microbiota Transplantation Network of academics (EurFMT), European Helicobacter & Microbiota Study Group"
OS113,11,S0421,08:30,"Quantifying the drivers of antiviral resistance: what (EHMSG) does it take to prevent resistance evolution?Roger Kouyos (Zürich, Switzerland)"
OS113,11,S0422,09:00,"Inferring the determinants of AMR dynamics across SY151 08:30 - 10:30 Hall 4 bacterial pathogensLulla Opatowski (Paris, France) 2-hour Symposium"
SY151,4,S0423,09:30,"Modelling the evolution of resistanceErida Gjini (Lisbon, Portugal) News in endocarditis care"
SY151,4,S0424,10:00,"Assessing the associations of microbiome and socio- Chairs Michele Bartoletti (Milan, Italy) demographic dynamics on AMRKatariina Pärnänen Pilar Retamar Gentil (Seville, Spain) (Helsinki, Finland)"
SY151,4,S0409,08:30,"Endocarditis guidelines: what is new?Siegbert Rieg 08:30 10:30 (Freiburg, Germany) Educational Session S0410 09:00 Oral therapy and outpatient careLaura Escolà-Vergé (Barcelona, Spain) Endemic mycoses and mycetoma: underdiagnosed and underreported fungal diseases S0411 09:30 PK/PD aspects of endocarditis antibiotic therapyFekade Bruck Sime (Brisbane, Australia) Chairs Ana Alastruey-Izquierdo (Madrid, Spain) Rita Oladele (Lagos, Nigeria) S0412 10:00 The Endocarditis Team: there is no way to work aloneBarbara Hasse (Zurich, Switzerland) Co-organised with: ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES), ESCMID Study Group for Antimicrobial"
SY151,4,W0433,08:30,"Advances and gaps in the diagnosis and treatment of stewardship (ESGAP), Sociedad Espanola de Infecciones Cardiovasculares histoplasmosisDiego Rodrigues Falci (Porto Alegre, (SEICAV) Brazil)"
SY151,4,W0434,08:50,"Paracoccidioidomycosis: an update on diagnostic challengesBeatriz L. Gomez (Bogota, Colombia) EF116 - Arena 2 09:30 10:30"
SY151,4,W0435,09:10,"What is new in TalaromycosisBrown Lottie (London, United Kingdom) ePoster Flash Session"
SY151,4,W0436,09:30,"Mycetoma: treatment challenges of a unique Sepsis revolutions: from machines to molecules neglected tropical diseaseBorna Nyaoke-Anoke Chair Pierluigi Del Vecchio (Roma, Italy) (Nairobi, Kenya)"
EW155,2,W0425,08:30,"The global epidemiology of arboviral diseasesChantal MDT/DTT carriageC. Bonazzetti* (Bologna, Italy), A. B.E.M. Reusken (Bilthoven, Netherlands) Grechi, D. Gibertoni, L. Mangione, F. Todisco, N. Caroccia, M. Rinaldi, R. Pascale, B. Tazza, A. Toschi,"
EW155,2,W0426,08:50,"Arboviral diseases transmitted by mosquitoesLuisa A. Amicucci, C. Campoli, Z. Pasquini, F. Calo', P. Barzon (Padua, Italy) Viale, M. Giannella"
EW155,2,W0427,09:10,Aboviral diseases transmitted by ticksJoanna Maria
EW155,2,W0428,09:30,"Arboviral diseases transmitted by sandfliesRémi Staphylococcus aureus bacteremia from a Charrel (Marseille, France) retrospective cohortP. Valsecchi* (Pavia, Italy), E. Co-organised with: EURL-PH-VBV, Polish Association of Epidemiologists and Bono, A. Valeretto, S. Resuli, M. Corbella, P. Infectiologists Cambieri, E. Seminari, R. Bruno"
SY150,3,S0405,08:30,How can we recognise and deal with adverse events
SY150,3,S0406,09:00,"What to check? – An attempt at evidence-based Rossaint, T. Vogl donor screeningElisabeth Terveer (Leiden,"
SY150,3,S0448,11:00,Challenges of diagnosis: do we need to treat all
SY150,3,S0449,11:30,"The role of CRISPR-Cas9-edited antiviral T cells against dsDNA virus infectionsTba C. diff challenges: insights into treatment, monitoring, and infection prevention Chair Kerrie Davies (Leeds, United Kingdom) FO167 - Arena 1 11:00 12:00 Open Forum"
SY150,3,F0454,11:00,"Typhoid vaccine roll outNginache Nampota Czech Republic), M. Brajerova, P. Kinross, P. (Baltimore, United States) Drevinek, M. Krutova"
SY150,3,F0455,11:10,Introduction of malaria vaccines to countries in sub-
SY150,3,F0456,11:20,"The story of COVID-19 vaccines in LMICPaul Adepoju Clostridioides difficile colitis.D.F. Bavaro* (Milan, (Perton, United Kingdom) Italy), D. Schumann, A. Cilli, L. Diella, D. Barbanotti, D. Mondatore, F. Medioli, M. Casana, A. Belati, L. Co-organised with: ESCMID Ethics Advisory Committee (EEAC) Bussini, V. Cento, R. Epis, M. Bartoletti"
SY150,3,E0888,11:00,Efficacy of High Dose Tigecycline-Containing
SY150,3,E0883,11:06,"Evaluation of CRS3123 compared to vancomycin for Wilcox, K. Davies the treatment of Clostridioides difficile infection"
SY150,3,E0884,11:12,"Phase 2/3, open-label, randomized, active-controlled"
SY150,3,E0885,11:18,"A Phase I, Randomized, Double-Blind, Placebo- D. Kavatha Controlled, Dose Escalation Study to Evaluate the Safety and Tolerability of Intravenous Ertapenem (ERT) with Zidebactam (ZID) in Combination (WCK"
SY150,3,E0886,11:24,Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC- producing K. pneumoniae infections – Results from a
SY150,3,M0450,11:00,"Anna Noel-Storr (Leamington Spa, United Kingdom) retrospective multicentre studyA. Marino* (Catania,"
SY150,3,M0451,11:12,"Jani Sormunen (Turku, Finland) Italy), A.E. Maraolo, M. Mazzitelli, A. Oliva, N. Co-organised with: European Centre for Disease Prevention and Control Geremia, A. De Vito, C. Gullotta, V. Scaglione, E. (ECDC) Vania, S. Lo Menzo, P. Navalesi, L. Volpicelli, A. Fiori, P. Prestifilippo, A. Cattelan, C.M. Mastroianni, G. Madeddu, B. Cacopardo, G. Nunnari"
SY150,3,E0887,11:30,Phase 3 study of oral gepotidacin for the treatment of 11:00 12:00 uncomplicated urinary tract infection in Japanese
SY150,3,E0889,11:36,"Efficacy of Ceftolozane/Tazobactam vs. Ceftazidime/Avibactam in the Treatment of Nosocomial Pneumonia Caused by Pseudomonas EF125 11:00 - 12:00 Arena 4 aeruginosa: a multicentric retrospective study from the SUSANA cohort.A. Bitti* (Sassari, Italy), A. De ePoster Flash Session Vito, M. Fois, E. Ricci, A. Bandera, A. Maccaro, S. Piconi, P. Maggi, G. Cenderello, M. Merli, G.V. De Bugs breaking the blood-brain barrier Socio, P. Morelli, P. Bonfanti, G. Madeddu Chair Markus Zeitlinger (Vienna, Austria)"
EF125,,E0890,11:42,"Experience of dalbavancin use for unlicensed indications in a UK tertiary infectious diseases settingC. Darlow* (Liverpool, United Kingdom), J."
EF125,,E0891,11:48,"Investigator-driven randomised controlled trial of Koedel* (Munich, Germany), S. Dyckhoff-Shen, I. cefiderocol versus standard therapy for healthcare- Masouris, H.W. Pfister, M. Klein associated and hospital-acquired gram-negative"
SY159,2,S0444,11:00,"Antimicrobial Stewardship in paediatrics across Beat the cancer by beating the infections different settingsTaylor Morrisette (Charleston, Chairs Daniela Maric (Novi Sad, Serbia) United States) Mojca Maticic (Ljubljana, Slovenia)"
SY159,2,S0445,11:30,"Stewardship in geriatrics: an exceedingly important targetDafna Yahav (Ramat-Gan, Israel)"
SY159,2,S0438,11:00,"Prevention of infection-associated cancer: learning from each otherCatharina Alberts (Amsterdam,"
SY159,2,S0439,11:30,"Test and treat early to prevent cancer: hepatitis B and hepatitis CFrancesco Negro (Geneva, Switzerland) Implementing AI in microbiological diagnostics: practical steps and quality control"
SY159,2,M0452,11:00,"Oliver Nolte (Zürich, Switzerland) Personalised patient management and infection prevention: Current evidence"
SY159,2,M0453,11:12,"Jennifer Dien Bard (Los Angeles, United States) and future perspectives Co-organised with: ESCMID Study Group for Genomic and Molecular Chairs Agnes Hajdu (Budapest, Hungary) Diagnostics (ESGMD), Swiss Society for Microbiology (SSM) Iris K. Minichmayr (Vienna, Austria)"
SY159,2,S0440,11:00,"The dosing perspective: towards individualised 1-hour Symposium treatment strategiesThomas Tängdén (Uppsala, Sweden) People-centred approach to strengthening the AMR response at primary care"
SY159,2,S0441,11:30,"The infection control perspective: advancing patient- Chairs Benedikt Huttner (Geneva, Switzerland) centred approachesAlessia Savoldi (Verona, Italy) Mirfin Mpundu (Lusaka, Zambia)"
SY159,2,S0446,11:00,"Implementation of WHO’s people-centred 1-hour Symposium interventionsNienke Van De sanDe Bruinsma (Geneva, Switzerland) Emerging fungal diseases in children: Global challenges and approach to"
SY159,2,S0447,11:30,"Opportunities for strengthening AMR interventions in management primary healthcareSholpan Kaliyeva (Karaganda City, Chairs Andreas H. Groll (Münster, Germany) Kazakhstan) Adilia Warris (Exeter, United Kingdom) Co-organised with: World Health Organisation (WHO)"
SY159,2,S0442,11:00,"Emerging fungal infections in immunocompromised 11:00 12:00 and geographically exposed childrenLaura Ferreras- 1-hour Oral Session Antolin (London, United Kingdom)"
SY159,2,S0443,11:30,"Best available treatments and options for children in Serious games - a serious business resource-limited settingsFabianne Carlesse (Sao Chairs Christian Kraef (Copenhagen, Denmark) Paulo, Brazil) Galadriel Pellejero-Sagastizábal (Zaragoza, Spain) Co-organised with: ESCMID Fungal Infection Study Group (EFISG), German- Speaking Mycological Society (DMykG)"
OS118,6,O0873,11:00,PRAISE hospital-onset bacteraemia and fungaemia
OS118,6,O0874,11:12,"Transforming hospital-onset bacteremia and Gallo, E. Durante-Mangoni fungemia data to the OMOP common data modelH. Düsseldorf* (Vienna, Austria), G. Duftschmid, E."
OS118,6,O0876,11:24,"Dutch Electronic Health Records in primary care: the Italy), R. Gallo, F. Patauner, F. Luciano, L. Bertolino, Nivel general practisioners databaseF.F. Stelma* A.M.C. Peluso, F. Boccia, R. Zampino, E. Durante- Mangoni (Utrecht, Netherlands), J. Van Summeren, M. Hooiveld, C. Baliatsas, V. Sankatsing, J. Schmitz, S."
OS118,6,O0877,11:36,"Local signs at catheter insertion sites: Insights from Enterococcus spp.: Experience from Seven Cases in a the multicenter DeepCath cohort study with 4,256 Referral CenterF. Frondizi* (Rome, Italy), G.M. Leanza, F. Catania, F. Sangiorgi, M. Chiuchiarelli, B. picturesN. Buetti* (Geneva, Switzerland), S. Ruckly, Andriolo, L. Vahedi, B. Liguoro, F. Giovannenze, E. A. Byczko, L. Gallay, A. Nguyen, H. Slimani, J.R. Zahar, Taddei, G. Scoppettuolo, C. Torti J.F. Timsit"
OS118,6,O0875,11:48,"Prospective evaluation of a machine learning-based Bacterial Endocarditis: A Case Series from a real-time multidrug-resistant organism prediction University HospitalG. Oliva* (Rome, Italy), F. systemV. Vasikasin* (Bangkok, Thailand), W. Giovannenze, G.M. Leanza, F. Frondizi, M. Nasomsong, A. Holmes, R.L. Peach, K. Bhangananda, Chiuchiarelli, B. Liguoro, B. Andriolo, E. Taddei, G. A. Myall, C.H. Yoon, D. Changpradub, S. Mookerjee, Scoppettuolo, C. Torti J. Price, B. Mauricio, T.M. Rawson"
EF131,,W0483,14:10,"Viruses in VAP and HAP: should we worry about them?Catia Cilloniz (Barcelona, Spain) EF134 13:30 - 14:30 Arena 4"
EF134,,W0484,14:30,"Optimising antibiotic therapy in VAPPinyo Rattanaumpawan (Bangkok, Thailand) ePoster Flash Session Infection Controller's Daily"
EF134,,S0465,13:30,"What answers can biofilm PK/PD modelling provide?Coen Van Hasselt (Leiden, Netherlands)"
EF134,,S0466,14:00,"subMIC antibiotic effects to improve biofilm PK/PD R. Zwittink, J. Kluytmans, D. Notermans parameters – still relevant?Francoise Van Bambeke (Brussels, Belgium)"
EF134,,S0467,14:30,"PK/PD-based optimisation of antibiotic treatments to retrospective case control studyM. Amar* (Haifa, suppress resistance in dynamic biofilm modelsMaria Israel), R. Najjar-Debbiny, G. Weber, R. Yasin, A. Dolores Macia Romero (Palma De Mallorca, Spain) Arbel, S. Shehade, I. Greenfeld, O. Salah, P. Shaked- S0468 15:00 Giving antibiotics an upper hand in the treatment of Mishan, O. Barnett-Griness biofilm infections – antibiotic augmenting"
EF134,,S0469,13:30,"Congenital cytomegalovirus detection by pool testing GermanyA. Rath* (Regensburg, Germany), B. in salivaGiannina Izquierdo (Santiago, Chile) Neumann, V. Rauschenberger, B. Kieninger, A. Eichner, J. Steinmann, S. Kampmeier, W. Schneider- S0470 14:00 Detection of blood-corne pathogens in asymptomatic Brachert blood donors by pool testingPatricia Alvarez (Rio De Janeiro, Brazil)"
EF134,,S0471,14:30,"Large-scale pooled testing to increase rapid faecium in Belgian hospitals (2022-2023)S. De molecular diagnostic test coverage for Koster* (Edegem, Belgium), S. Van Kleef-Van tuberculosisMelissa Sander (Bamenda, Cameroon) Koeveringe, H. Jansens, S. Vandamme, T. S0472 15:00 Pool testing for screening of bacterial sexually Demuyser, M. Vanden Driessche, Y. Glupczynski, S. transmitted infectionsTba Malhotra-Kumar, V. Matheeussen"
EF134,,W0481,13:30,"Artificial Intelligence to predict VAPMiia Jansson pathogens in bronchoalveolar lavage fluid: a (Oulu, Finland) diagnostic aid for invasive fungal infectionsS. Zhang*"
EF134,,W0482,13:50,"Metagenomic approach to VAP diagnosisJacques (Baltimore, United States)"
EF134,,S0464,15:00,"Tailoring treatment to resistant Gram-negative in non-HIV populationA. Falcó Roget* (Mataró, bacteria: newer therapeutic approachesJuan P. Spain), A. Falcó-Roget, A. Albasanz-Puig, A.B. Pérez, Horcajada (Barcelona, Spain) S. Serradell, A. Guillén, E. Revilla, I. Los-Arcos, O. Len, I. Ruiz-Camps, M.T. Martín-Gómez Co-organised with: ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)"
EF134,,W0477,13:30,"Parasitic diseases: dermatological manifestations in Chair Barbara C. Kahl (Münster, Germany) the tropicsKirti Sabnis (India)"
EF134,,W0478,13:50,"Madura foot and other implantation mycosesM Ramam (New Delhi, India)"
EF134,,S0457,13:30,"S. aureus and its special relationship to S. W0479 14:10 MycobacteriaFrancisco Bravo (Lima, Peru) epidermidis Andreas Peschel (Tübingen, Germany)"
EF134,,W0480,14:30,Approach to rash in the returning travellerFrank O. D.
EF134,,S0458,14:00,"Computational and in vitro evaluation of probiotic Pettersen (Oslo, Norway) treatments for nasal S. aureus decolonizationSilvio Daniel Brugger (Zurich, Switzerland)"
EF134,,S0459,14:30,"Clonal population expansion of S. aureus occurs due OS127 13:30 - 14:30 Hall 6 to escape from a finite number of intraphagocyte nichesSimon Foster (Sheffield, United Kingdom) 1-hour Oral Session"
OS127,6,S0460,15:00,"How bacteriophages and pathogenicity islands drive The good, the bad and the itchy: update on STIs the evolution of S. aureus John Chen (Singapore, Singapore) Chair Tatum Mortimer (Athens, United States) Co-organised with: ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS)"
OS127,6,W0473,13:30,"Hepatitis B during pregnancy: diagnosis, management and outcomeTba O0922 The Gonococcus Bacterial Load Measured by the Cycle Threshold (Ct) in Urinary Samples Correlates"
OS127,6,W0474,13:50,"RSV and Influenza during pregnancy: management with SymptomatologyG. Beraud* (Orleans, France), and outcomeMonika Redlberger-Fritz (Vienna, T. Prazuck, L. Barhoum, H. Meyjonnade, J. Effa, L. Austria) Hocqueloux, A. Seve, J. Guinard, K. Kochbati, E."
OS127,6,W0475,14:10,"Prenatal screening and prevention of congenital Carbonelle, C. Guillaume CMV: shifting concepts and consensus O0923 STI pathogen interactions and viability in men who guidelineMarianne Leruez-Ville (Paris, France) have sex with men (MSM)E. Rayo* (Zurich,"
OS127,6,W0476,14:30,"Novel methods of vaccine administration to Switzerland), D. Onorini, C. Leonard, H. Marti, T. newbornsTba Pesch, B. Hampel, N. Low, N. Borel Co-organised with: ESCMID Study Group for Viral Hepatitis (ESGVH), O0924 Epidemiology of bacterial genitourinary infections European Society for Infectious Diseases in Obstetrics and Gynaecology among women with recurrent vulvovaginal (ESIDOG), Society on Liver Diseases in Africa (SOLDA), Gastroenterology and Candidiasis (RVVC) in Nigeria.S. Fayemiwo* (Ibadan, Hepatology Association of SubSaharan Africa (GHASSA) Nigeria), L. Novak-Frazer, I. Adewole, R. Rautemaa- Richardson"
OS127,6,S0461,13:30,"Globally emerging resistance patterns of O0930 Influence of non-coding small RNA00203 in biofilm EnterobacteralesSasheela Ponnampalavanar (Kuala cells of Acinetobacter baumannii: Transcriptomic and Lumpur, Malaysia) phenotypicD. Gebrelibanos* (Hong Kong, China), P."
OS127,6,S0462,14:00,"Non-fermenters still important globally: a review of Leung, A.M. Shenkutie, F. Chow spread and resistanceAnupa Thampy (Vellore, India) O0931 Sub-MIC antibiotic effects on Pseudomonas aeruginosa biofilm streamer formationA. Di Claudio*"
OS127,6,S0463,14:30,"Innovative rapid diagnostic methodologies for Gram- (Pieve Emanuele, Italy), R. Rusconi, E. Secchi, G. negative pathogensLaurent Dortet (Le Kremlin- Savorana"
